PREFACE AMENDMENTS TO THE DRUG TARIFF April 2022, Summaries of Business

Download PREFACE AMENDMENTS TO THE DRUG TARIFF April 2022 and more Summaries Business in PDF only on Docsity! i 04/2022 PREFACE AMENDMENTS TO THE DRUG TARIFF April 2022 1. In accordance with regulation 89(3) of the National Health Service (Pharmaceutical and Local Pharma- ceutical Services) Regulations 2013 (“the 2013 Regulations”), the Secretary of State for Health as re- spects England and in accordance with regulation 41(4) of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2013, the Welsh Ministers* as respects Wales have amended the Drug Tariff and determinations made in respect of the amendments to the Drug Tariff shall have effect from 1 August 2015. For England, by virtue of regulation 91(1) of the 2013 Regulations, the NHS Commissioning Board (“the Board”) has been appointed as a determining authority in relation to the pharmaceutical remuneration listed Schedule 8 to the 2013 Regulations (ie types of service remuneration) and remuneration for advanced services. This means that both the Secretary of State and the Board are able to determine remuneration in these areas, although if the Secretary of State determines remuneration in these areas, he is required to notify the Board of his intention to do so before doing so. As part of a phased transfer of responsibilities between the Secretary of State and the Board, the Board will be acting as the lead determining authority in relation to the following Parts: • Part IIIA • Part IIIB • Part VIA • Part VIB • Part VIC (up to Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions 2013) By virtue of Part VIE, the Board is also a determining authority for England for the remuneration for enhanced services and acts as the lead determining authority in that area. The Secretary of State is the sole determining authority for all other Parts. Part XI, XIVD, XVIIID and XXI are rescinded in this edition of the Drug Tariff. Before the Secretary of State, NHS Commissioning Board and the Welsh Ministers make further determinations they will consult with such organisations as appear to be representative of persons to whose remuneration the determination would relate and such other persons as they consider appropriate in respect of determinations which relate to persons providing pharmaceutical services, or a category of such services in accordance with section 165 of the National Health Service Act 2006 and section 89 of the National Health Service (Wales) Act 2006, regulations made under those sections and under section 164 of the National Health Service Act 2006 and section 88 of the National Health Service (Wales) Act 2006. i) Effective date for all parts except those indicated in (ii) 1st day of the month ii) Effective date for specific provisions in specified parts N/A iii) Date of publication 1st day of the month TO: General Medical Practitioners, Pharmacy Contractors, Appliance Contractors ii 04/2022 PREFACE 2. Please note that you are now being supplied each month with the Drug Tariff which incorporates all amendments to date and this will continue until April 2021, when the Drug Tariff will no longer be printed and distributed (please see paragraph 4 for further information regarding these changes to the circulation of the Drug Tariff). All entries showing a change in price are not specifically included in this preface but are indicated in the Drug Tariff by L for price reduction and K for price increase; changes to the text re- lating to code, product description, or the inclusion of a new product are indicated by a vertical line in the margin. 3. While every effort is made to ensure that each monthly publication of the Drug Tariff includes all amendments made by the Secretary of State and the Welsh Ministers to the price applicable to the rele- vant period, the need to observe publishing deadlines sometimes defeats those efforts. Any omitted amendments will be effective from the date on which they came into force, even if publication of the details is unavoidably delayed. * Functions of the National Assembly for Wales have transferred to Welsh Ministers in accordance with section 162 of and paragraph 30 of Schedule 11 to the Government of Wales Act 2006. v 04/2022 PREFACE 5.13 PART XVIIID - THE NATIONAL HEALTH SERVICE LITIGATION AUTHORITY (PHARMACEUTICAL REMUNERATION - PAYMENT DISPUTES) (ENGLAND) DIRECTIONS 2022 Contractors should note the replacement of the Directions. 5.14 ADDITIONS TO APRIL 2022 DRUG TARIFF 5.14.1 PART II - REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS PAGE 22 - DRUGS FOR WHICH DISCOUNT IS NOT DEDUCTED Individual Items Aldara 5% cream 250mg sachets PAGE 28 Famvir 125mg tablets PAGE 30 GlucoRx Aidex Sensor Granisetron 3.1mg/24hours transdermal patches PAGE 36 Phosphates enema (Formula B) 128ml standard tube PAGE 39 Sancuso 3.1mg/24hours transdermal patches 5.14.2 PART VIIIA - BASIC PRICES OF DRUGS PAGE 254 PAGE 318 PAGE 352 PAGE 360 5.14.3 PART IXA - APPLIANCES PAGE 437 - DETECTION SENSOR, INTERSTITIAL FLUID FOR GLUCOSE S Special container Artemether 20mg / Lumefantrine 120mg tablets 24 2250 C Riamet Levofloxacin 5mg/ml eye drops 0.5ml unit dose preservative free 20 (4xS5) 1525 C Oxalux Propylthiouracil 100mg tablets 56 4050 A Propylthiouracil 25mg tablets 28 3232 A Sodium bicarbonate 500mg gastro-resistant capsules 100 1875 C Nephrotrans GlucoRx Aidex Sensor 1 2995 vi 04/2022 PREFACE PAGE 511 - EYE PRODUCTS Eye Drops - Carmellose PAGE 513 Eye Drops - Hypromellose PAGE 514 Eye Drops - Sodium Hyaluronate 5.14.4 PART IXB - INCONTINENCE APPLIANCES PAGE 694 - NIGHT DRAINAGE BAGS Great Bear Healthcare Ltd 5.14.5 PART XV - BORDERLINE SUBSTANCES PAGE 1031 - LIST A Foodlink Aqua For the dietary management of disease-related malnutrition. PAGE 1032 Foodlink Extra (Banana, Chocolate, Strawberry and Vanilla Flavours) For the dietary management of disease-related malnutrition. Foodlink Extra Starter Pack For the dietary management of disease-related malnutrition. Foodlink Smoothie (Orange & Mango, Peach, Red Berry and Tropical Flavours) For the dietary management of disease-related malnutrition. Foodlink Smoothie Starter Pack For the dietary management of disease-related malnutrition. PAGE 1044 KetoClassic 3:1 Bisk For the dietary management of intractable epilepsy, pyruvate dehydrogenase deficiency, glucose transporter type 1 deficiency and other conditions where a ketogenic diet is indicated. 5.14.6 PART XVI - NOTES ON CHARGES PAGE 1113 - LIST OF CONTRACEPTIVE DRUGS TO BE DISPENSED FREE OF CHARGE: Ethinylestradiol 20microgram / Desogestrel 150microgram tablets AaqEye Carmellose 0.5% (10ml bottle) 173 AaproMel (10ml bottle) 69 ClinOptic HA 0.1% (10ml preservative free bottle) 415 ClinOptic HA 0.21% (10ml preservative free bottle) 415 S Sterile U Single Use Only SU GB5S 3 litre sterile night bag with 120cm tube, single use T-tap and safety clip 10GB5S 10 864 vii 04/2022 PREFACE 5.15 DELETIONS FROM APRIL 2022 DRUG TARIFF 5.15.1 PART VIIIA - BASIC PRICES OF DRUGS PAGE 254 PAGE 276 5.15.2 PART VIIIB - ARRANGEMENTS FOR PAYMENT FOR SPECIALS AND IMPORTED UNLICENSED MEDICINES WITH A PRICE PER UNIT ABOVE A MINIMUM QUANTITY PAGE 383 PAGE 384 5.15.3 PART IXA - APPLIANCES PAGE 426 - CATHETERS, URINARY, URETHRAL (B)(i)(a) Foley Catheter - 2 Way (indwelling Nelaton catheter with Balloon) For Short/medium Term Use - Adult PAGE 427 (B)(i)(b) Foley Catheter - 2 Way (indwelling Nélaton catheter with balloon) For Short/Medium Term Use - Paediatric PAGE 428 (B)(ii)(a) Foley Catheter - 2 Way For Long Term Use - Adult Aspirin 300mg dispersible tablets 100 328 M Co-triamterzide 50mg/25mg tablets 30 95 C Dyazide Atorvastatin 20mg/5ml oral suspension STD, SF, NSF, AF, FF, CF, LF 100ml 2429 6 Chloral hydrate 500mg/5ml oral solution STD, SF, CF, NSF, FF, AF, LF, PF 100ml 1082 4 Bard Ltd Bard PTFE Coated Latex pack of 1 (Male) (D1265LV) 10 12-26 286 (Female) (D0169LV) 10 12-22 427 Bard PTFE Aquamatic Coated Latex pack of 1 (D1265AL) 10 12-22 326 pack of 1 Bard PTFE Coated Latex (D0165PV) 5 8-10 789 Bard Lubri-Sil Hydrogel Coated Silicone pack of 1 (Male) (D176816-22E) 30 16-22 997 Bard Silicone Elastomer Coated Latex pack of 1 (Male) (D1657) 10 12-22 969 (Female) (D1647) 30 16 969 Bard Silicone Elastomer Coated Latex pack of 1 (Male) (D1657AL) 10 12-22 1047 (Female) (D1637AL) 10 12-22 1047 x 04/2022 PREFACE PAGE 879 - ILEOSTOMY (DRAINABLE) BAGS Pelican Healthcare Ltd Pelican Platinum Contour Drainable Pouch with soft foam backed contour skin protector, fabric on both sides, split fabric backing for viewing/positioning, hydrophobic filter and clipless outlet PAGE 880 Pelican Platinum Drainable Pouch with soft foam backed skin protector, fabric on both sides, split fabric backing for viewing/positioning, hydrophobic filter and clipless outlet PAGE 883 Pelican Select Afresh - Drainable Pouch with Clipless System & Integral Filter PAGE 884 Pelican Select Afresh - Drainable Pouch with filter PAGE 885 Pelican Select Drainable Convex Pouch - integral convexity with filter, split fabric backing and clipless outlet Pelican Select Drainable DuoVent - with two filters, easy access outlet, skin protector, fabric both sides PAGE 958 - TWO PIECE OSTOMY SYSTEMS Pelican Healthcare Ltd Pelican Platinum 2 piece flat baseplate Clear Standard pre-cut 20mm 218420 30 10107 22.5mm 218422 30 10107 27.5mm 218427 30 10107 37.5mm 218437 30 10107 Clear Standard pre-cut 22.5mm 118422 30 10107 32.5mm 118432 30 10107 50mm 118450 30 10107 Pelican Select Paediatric Pouch - with skin protector, fabric both sides with printed motif Clear cut-to-fit 10mm-50mm 101601 30 7547 Neonatal Pouch - Plain split fabric front and back Clear cut-to-fit 10mm-50mm 101604 30 7291 Opaque Maxi pre-cut 20mm 112520 30 9107 32.5mm 112532 30 9107 Clear Maxi pre-cut 27.5mm 112627 30 9107 32.5mm 112632 30 9107 35mm 112635 30 9107 37.5mm 112637 30 9107 50mm 112650 30 9107 Opaque Standard pre-cut 20mm 112120 30 9107 Clear Standard pre-cut 37.5mm 112237 30 9107 Opaque Mini pre-cut 25mm 112325 30 9107 35mm 112335 30 9107 45mm 112345 30 9107 Opaque - Maxi cut-to-fit 37.5mm 113537 10 4623 Clear - Mini cut-to-fit 15-65mm 111200 30 8058 Opaque - Mini cut-to-fit 15-65mm 111215 30 8058 60mm ring pre-cut 27.5mm 600027 5 2023 xi 04/2022 PREFACE PAGE 983 - UROSTOMY BAGS Pelican Healthcare Ltd Pelican Platinum Contour Convex urostomy pouch with soft foam backed convex contour skin protector, fabric on both sides, split fabric backing for viewing/positioning and soft bung Pelican Platinum Contour Convex urostomy pouch with soft foam backed convex contour skin protector, fabric on both sides, split fabric backing for viewing/positioning, tap and 2 adaptors for a night drainage bag Pelican Platinum Convex urostomy pouch with soft foam backed convex skin protector, fabric on both sides, split fabric backing for viewing/positioning and soft bung PAGE 984 Pelican Platinum Convex urostomy pouch with soft foam backed convex skin protector, fabric on both sides, split fabric backing for viewing/positioning, tap and 2 adaptors for a night drainage bag Pelican Platinum with Vitamin E Convex Urostomy Pouch with soft foam backed contour skin protector containing Vitamin E, fabric on both sides, split fabric backing for viewing/positioning and flexible bung PAGE 985 Pelican Select Urostomy Pouch with soft covering to both sides Pelican Select Convex Urostomy Pouch with soft convexity 5.15.5 PART IXR - CHEMICAL REAGENTS PAGE 996 - DETECTION STRIPS, BLOOD FOR GLUCOSE Biosensor Strips - to be read only with the appropriate meter Clear Standard pre-cut 20mm 421420 10 5813 35mm 421435 10 5813 Clear Standard pre-cut 20mm 423420 10 6026 35mm 423435 10 6026 40mm 423440 10 6026 Clear Mini cut-to-fit 12-40mm 423212 10 6026 Clear Standard pre-cut 20mm 321420 10 5813 25mm 321425 10 5813 35mm 321435 10 5813 Clear Standard pre-cut 25mm 323425 10 6026 30mm 323430 10 6026 35mm 323435 10 6026 Clear Maxi cut-to-fit 12-40mm 323612 10 6026 Clear Standard pre-cut 35mm 421435E 10 5818 40mm 421440E 10 5818 pre-cut 37.5mm 114237 30 16736 40mm 114240 30 16736 55mm 114255 30 16736 pre-cut 37.5mm 115437 10 5753 Omnitest 3 50 989 Omnitest 5 50 989 xii 04/2022 PREFACE 5.16 OTHER CHANGES TO APRIL 2022 DRUG TARIFF 5.16.1 PART II - REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS PAGE 34 - DRUGS FOR WHICH DISCOUNT IS NOT DEDUCTED Individual Items MMA/PA amino5 oral powder 6g sachets Now Reads MMA / PA amino5 oral powder 6g sachets 5.16.2 PART VIIIA - BASIC PRICES OF DRUGS PAGE 247 Now Reads PAGE 259 Now Reads PAGE 269 Now Reads PAGE 270 Now Reads S Special container Acamprosate 333mg gastro- resistant tablets 168 4244 A Acamprosate 333mg gastro- resistant tablets 168 2570 M Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free 30 1687 A Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free 30 (6xS5) 1789 A Ciclosporin 0.1% eye drops 0.3ml unit dose 30 7200 C Ikervis Ciclosporin 0.1% eye drops 0.3ml unit dose 30 (6xS5) 7200 C Ikervis Ciprofloxacin 2mg/ml ear drops 0.25ml unit dose preservative free 15 601 C Cetraxal Ciprofloxacin 2mg/ml ear drops 0.25ml unit dose preservative free 15 (3xS5) 601 C Cetraxal xv 04/2022 PREFACE 5.16.3 PART VIIID - ARRANGEMENTS FOR PAYMENT FOR SPECIALS AND IMPORTED UNLICENSED MEDICINES WITH PRICES DETERMINED RELATIVE TO A COMMONLY IDENTIFIED PACK SIZE PAGE 395 Now Reads 5.16.4 PART IXA - APPLIANCES PAGE 474 - DRESSINGS Wound Management Dressings Protease Modulating Matrix - Sterile Now Reads PAGE 509 - EMOLLIENT AND BARRIER PREPARATIONS Preparations containing Urea Now Reads Flunarizine dihydrochloride 10mg tablets STD 30 18031 Flunarizine dihydrochloride 5mg capsules STD 50 16273 Flunarizine 10mg tablets STD 30 18031 Flunarizine 5mg capsules STD 50 16273 R Please refer to manufacturer for availability o Products marked with this symbol must be dispensed with a supply of wipes and disposal bags Q These product codes will change in the April 2022 Drug Tariff DryMax Extra Soft Square 10cm x 10cm 88 20cm x 20cm 187 Rectangular 10cm x 20cm 105 20cm x 30cm 236 37cm x 56cm 486 DryMax Super (including products formerly listed as DryMax Extra Soft) Square 10cm x 10cm 88 20cm x 20cm 187 Rectangular 10cm x 11cm 88 10cm x 20cm 105 11cm x 20cm 105 20cm x 30cm 236 37cm x 56cm 486 Balneum Cream 50g pump 285 500g pump 997 Balneum Intensiv Cream (formerly Balneum Cream) 50g pump 285 500g pump 997 xvi 04/2022 PREFACE PAGE 652 - TRACHEOSTOMY AND LARYNGECTOMY APPLIANCES Tracheostomy Breathing Aids Now Reads Now Reads Now Reads Now Reads Now Reads Ro Shiley Tracheostomy System o Shiley Tracheostomy System Q Shiley Uncuffed Paediatric Tracheostomy tube 39 mm length Diam 3.0mm inner, 4.5mm outer 3.0PED 2970 40mm length Diam 3.5mm inner, 5.2mm outer 3.5PED 2970 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PED 2970 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PED 2970 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PED 2970 45mm length Diam 5.5mm inner, 7.7mm outer 5.5PED 2970 Shiley Uncuffed Paediatric Tracheostomy tube 39 mm length Diam 3.0mm inner, 4.5mm outer 3.0PEF 2970 40mm length Diam 3.5mm inner, 5.2mm outer 3.5PEF 2970 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PEF 2970 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PEF 2970 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PEF 2970 45mm length Diam 5.5mm inner, 7.7mm outer 5.5PEF 2970 Q Shiley Long Uncuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PDL 3245 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PDL 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PDL 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PDL 3455 Shiley Long Uncuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PELF 3245 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PELF 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PELF 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PELF 3455 Q Shiley Cuffed Paediatric Tracheostomy tube 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PDC 3444 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PDC 3444 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PDC 3444 46mm length Diam 5.5mm inner, 7.7mm outer 5.5PDC 3444 Shiley Cuffed Paediatric Tracheostomy tube 41mm length Diam 4.0mm inner, 5.9mm outer 4.0PCF 3444 42mm length Diam 4.5mm inner, 6.5mm outer 4.5PCF 3444 44mm length Diam 5.0mm inner, 7.1mm outer 5.0PCF 3444 46mm length Diam 5.5mm inner, 7.7mm outer 5.5PCF 3444 Q Shiley Long Cuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PLC 3455 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PLC 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PLC 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PLC 3455 Shiley Long Cuffed Paediatric Tracheostomy tube 50mm length Diam 5.0mm inner, 7.1mm outer 5.0PLCF 3455 52mm length Diam 5.5mm inner, 7.7mm outer 5.5PLCF 3455 54mm length Diam 6.0mm inner, 8.3mm outer 6.0PLCF 3455 56mm length Diam 6.5mm inner, 9.0mm outer 6.5PLCF 3455 xvii 04/2022 PREFACE Now Reads Now Reads PAGE 653 Now Reads Now Reads Q Shiley Low Pressure Cuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4LPC 5429 76mm length Diam 7.0mm inner, 10.8mm outer 6LPC 5429 81mm length Diam 8.5mm inner, 12.2mm outer 8LPC 5429 81mm length Diam 9.0mm inner, 13.8mm outer 10LPC 5429 Shiley Low Pressure Cuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4CN65R 5429 76mm length Diam 7.0mm inner, 10.8mm outer 6CN75R 5429 81mm length Diam 8.5mm inner, 12.2mm outer 8CN85R 5429 81mm length Diam 9.0mm inner, 13.8mm outer 10CN10R 5429 Q Shiley Uncuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4CFS 5237 76mm length Diam 6.4mm inner, 10.8mm outer 6CFS 5237 81mm length Diam 7.6mm inner, 12.2mm outer 8CFS 5237 81mm length Diam 8.9mm inner, 13.8mm outer 10CFS 5237 Shiley Uncuffed Tracheostomy tube with reusable inner cannula 65mm length Diam 5.0mm inner, 9.4mm outer 4UN65R 5237 76mm length Diam 6.4mm inner, 10.8mm outer 6UN75R 5237 81mm length Diam 7.6mm inner, 12.2mm outer 8UN85R 5237 81mm length Diam 8.9mm inner, 13.8mm outer 10UN10R 5237 Q Shiley Low Pressure Cuffed Tracheostomy tube with Disposable inner cannula 62mm length Diam 5.0mm inner, 9.4mm outer 4DCT 5237 74mm length Diam 6.4mm inner, 10.8mm outer 6DCT 5237 79mm length Diam 7.6mm inner, 12.2mm outer 8DCT 5237 79mm length Diam 8.9mm inner, 13.8mm outer 10DCT 5237 Shiley Low Pressure Cuffed Tracheostomy tube with Disposable inner cannula 62mm length Diam 5.0mm inner, 9.4mm outer 4CN65A 5237 74mm length Diam 6.4mm inner, 10.8mm outer 6CN75A 5237 79mm length Diam 7.6mm inner, 12.2mm outer 8CN85A 5237 79mm length Diam 8.9mm inner, 13.8mm outer 10CN10A 5237 Q Shiley Uncuffed Tracheostomy tube with Disposable inner cannula 62mm length Diam 5.0mm inner, 9.4mm outer 4DCFS 5237 74mm length Diam 6.4mm inner, 10.8mm outer 6DCFS 5237 79mm length Diam 7.6mm inner, 12.2mm outer 8DCFS 5237 79mm length Diam 8.9mm inner, 13.8mm outer 10DCFS 5237 Shiley Uncuffed Tracheostomy tube with Disposable inner cannula 62mm length Diam 5.0mm inner, 9.4mm outer 4UN65A 5237 74mm length Diam 6.4mm inner, 10.8mm outer 6UN75A 5237 79mm length Diam 7.6mm inner, 12.2mm outer 8UN85A 5237 79mm length Diam 8.9mm inner, 13.8mm outer 10UN10A 5237 2 04/2022 CONTENTS Part XVIIIC Criteria notified under the Transparency Directive ............................................. 1161 Part XVIIID The National Health Service Litigation Authority (Pharmaceutical Remuneration - Pay- ment Disputes) (England) Directions 2022 ........................................................ 1162 Part XIX Payments to Chemists Suspended by the NHS Commissioning Board or by Direction of the First-Tier Tribunal ..................................................................................... 1166 Part XX Requisitions and Private Prescriptions for Controlled Drugs.............................. 1171 Part XXI Rescinded - Intentionally Blank.......................................................................... 1173 3 04/2022 Definitions Definitions - DEFINITIONS (a) Except where the context otherwise requires, the terms to which a meaning is assigned by the Regulations or the Terms of Service have the same meaning in this Tariff. (b) The term ‘contractor’ has for Wales the same meaning as ‘chemist’ as defined in the National Health Service (Pharmaceutical Services) Regulations 1992 and for England the same meaning as ‘NHS chemist’ as defined in the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013. LPS chemists will also need to be paid at least part of their remuneration (depending on the terms of their scheme) in accordance with the Drug Tariff, and so at least some references to ‘contractor’ will apply equally to them. (c) A pharmacy contractor is a person with whom the NHS Commissioning Board (NHSCB) for England and Local Health Board (LHB) for Wales has made arrangements for the provision of pharmaceutical services in respect of the supply of drugs, appliances and chemical reagents. (d) An appliance contractor is a person with whom the NHSCB for England and LHB for Wales has made arrangements for the provision of pharmaceutical services so far as it relates to the supply of appliances included within Part IXA/B/C of this Tariff. (e) The term persons includes a body of persons corporate or unincorporate. (f) The term Pricing Authority means, as the case may require, the NHS Business Services Authority (NHSBSA) or the NHS Wales Shared Services Partnership (NWSSP). (g) The term appliances as used in this Tariff includes dressings. (h) The term prescription refers to an item on a prescription form or dispensed in accordance with a repeatable prescription. (i) The term prescription form includes, where appropriate, a repeatable prescription. (j) The term pharmacy means any premises where drugs are provided by a pharmacist or pharmacy business as part of pharmaceutical services under section 126 (arrangements for pharmaceutical services) for England of the National Health Service Act 2006 and Section 80 of the National Health Service (Wales) Act 2006. (k) Specials are unlicensed medicinal products manufactured in the UK for human use which have been specially prepared to meet a prescription ordered for individual patients without the need for the manufacturer to hold a marketing authorisation for the medicinal product concerned. (l) Imported products are unlicensed medicinal products sourced from outside the UK under an importers licence issued by the MHRA. These products have been specially sourced to meet a prescription ordered for individual patients without the need for the importer to hold a marketing authorisation for the medicinal product concerned. In the preparation of this Tariff the Secretary of State for Health and the Welsh Ministers have consulted the Pharmaceutical Services Negotiating Committee. 4 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Part I - Requirements for the Supply of Drugs, Appliances and Chemical Reagents CLAUSE 1 DRUGS Any drug included in this Tariff or in the British National Formulary including the Nurse Prescribers' Formulary, Dental Practitioner's Formulary, European Pharmacopoeia, British Pharmacopoeia or the British Pharmaceutical Codex, supplied as part of pharmaceutical services, must comply with the standard or formula specified therein unless the prescriber has indicated to the contrary. Any drug supplied which is not so included must be of a grade or quality not lower than that ordinarily used for medicinal purposes. CLAUSE 2 APPLIANCES The only appliances which may be supplied as part of the pharmaceutical services are those listed in Part IXA/ B/C, and Part X (see Clause 4 below), of the Tariff and which comply with the specifications therein. The items within Part IXA which are not prescribable on Forms FP10(CN) and FP10(PN) are annotated 2 CLAUSE 3 CHEMICAL REAGENTS The only chemical reagents which may be supplied as part of the pharmaceutical services are those listed in Part IXR of the Tariff. The items within Part IXR which are not prescribable on forms FP10(CN) and FP10(PN) are annotated 2 CLAUSE 4 DOMICILIARY OXYGEN THERAPY SERVICE The requirements for the supply of domiciliary oxygen and its associated appliances together with the arrangements for reimbursement of those contractors included on the CCG’s for England and LHB's for Wales lists of contractors authorised to provide this service, are set out in Part X of the Tariff. CLAUSE 5 PAYMENTS FOR PROVIDING PHARMACEUTICAL SERVICES CLAUSE 5A CLAIMS FOR PAYMENTS Claims for payment for England only up until March 2022 (February 2022 prescriptions) 1. Paper prescriptions - contractors must: (a) Endorse prescription forms1 as required in Clause 9 (Endorsement Requirements) of this Tariff; and (b) Dispatch the prescription forms to the relevant division of the NHS Business Service Authority: NHS Prescription Services for England: (i) with the appropriate claim form (also referred to as the FP34C form2); (ii) sorted as appropriate; (iii) in a secure manner that enables tracking and tracing of the delivery; and (iv) not later than the 5th day of the month following that in which the supply was made3. 1 For the purpose of Part I of the Drug Tariff, wherever prescriptions, prescription forms or batch issues are mentioned, this includes prescription forms where supply was made in accordance with a Serious Shortage Protocol (SSP). 2 Contractors should note that the FP34C is available online on the Manage Your Service (MYS) portal and in paper form. However, from April 2022 the form will be available online only. Contractors, who use the MYS portal, must print off the populated FP34C from the portal and dispatch it alongside the batch of paper prescriptions. 3 Where one or more bank holiday occurs within the first five days of the month, dispatch must be secured by the 6th of that month. Note: for contractors, who use the FP34C on MYS, they must complete and submit it by the 6th of the month including where needed printing the populated FP34C and dispatching it alongside the batch of paper prescriptions. 2. Repeat dispensing services - contractors must: (a) endorse batch issues as required in Clause 9 (Endorsement Requirements) of this Tariff. In addition, batch issues relating to drugs, appliances or chemical reagents which have been dispensed must be stamped with the contractor's stamp and dated with the date on which the items were dispensed. (b) dispatch the batch issues (in the same parcel as per Clause 5A 1) relating to drugs, appliances or chemical reagents which have been dispensed to the NHS Prescription Services for England: 7 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Claims for payment for England only from November 2021 (October 2021 prescriptions)9 6. Paper prescriptions - contractors must: (a) Endorse prescription forms10 as required in Clause 9 (Endorsement Requirements) of this Tariff; and (b) Dispatch the prescription forms to the relevant division of the NHS Business Service Authority: NHS Prescription Services for England: (i) sorted as appropriate; (ii) in a secure manner that enables tracking and tracing of the delivery; and (iii) not later than the 5th day of the month following that in which the supply was made11. (c) Populate the appropriate claim form on the Manage Your Service (MYS) platform to reflect claims for paper prescription and submit it electronically by no later than the 5th day of the following month in which the supply was made12. Contractors must also print the populated FP34C form from the MYS platform and dispatch it alongside the paper prescriptions as per Clause 5A 6 (b). 7. Repeat dispensing services - contractors must: (a) endorse batch issues as required in Clause 9 (Endorsement Requirements) of this Tariff. In addition, batch issues relating to drugs, appliances or chemical reagents which have been dispensed must be stamped with the contractor's stamp and dated with the date on which the items were dispensed. (b) dispatch the batch issues relating to drugs, appliances or chemical reagents which have been dispensed to the NHS Prescription Services for England: (i) sorted as appropriate; (ii) in a secure manner that enables tracking and tracing of the delivery; and (iii) by no later than the 5th day of the month following that in which the supply was made13; (c) destroy any batch issues relating to drugs, appliances or chemical reagents which are not required, or which should not be dispensed because the contractor has been notified to that effect by the doctor who issued them or because the relevant repeatable prescription has expired; and (d) populate the appropriate claim form on the Manage Your Service (MYS) platform to reflect repeat dispensing services and submit it by no later than the 5th day of the following month in which the supply was made14. Contractors must also print the populated FP34C from the MYS platform and submit it alongside paper prescriptions as per Clause 5A 6 and 7. 9 Pharmacy contractors should note that until March 2022 two systems will be run concurrently – for those pharmacy contractors who wish to continue to use paper FP34C and receive payment as per Clause 5C1(a) and for those who wish to use MYS platform to populate their FP34C and receive payment as per Clause 5C1(d). From April 2022, only the timetable outlined in Clause 5C1(d) will be in place (i.e. all pharmacy contractors will have to use MYS). 10 For the purpose of Part I of the Drug Tariff, wherever prescriptions, prescription forms or batch issues are mentioned, this includes prescription forms where supply was made in accordance with a Serious Shortage Protocol (SSP). 11 Where one or more bank holiday occurs within the first five days of the month, dispatch must be secured by the 6th of that month. Note: The requirement to submit EREMs within the first 5 days remains unchanged. 12 Where one or more bank holiday occurs within the first five days of the month, MYS submission must be completed and submitted by the 6th of the month. 13 Where one or more bank holiday occurs within the first five days of the month, dispatch must be secured by the 6th of that month. Note: The requirement to submit EREMs within the first 5 days remains unchanged. 14 Where one or more bank holiday occurs within the first five days of the month, MYS submission must be completed and submitted by the 6th of the month. 8 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS 8. Prescriptions via the Electronic Prescription Service - contractors must: (a) ensure that the Electronic Reimbursement Endorsement Messages (EREMs)15 include the endorsement requirements as required by Clause 9, Part II, and submit the EREMs via EPS to NHS Prescription Services for England for receipt at the Pricing Authority by no later than the 5th day of the month following that in which the supply was made16. Contractors should note that any EREMs sent after the 5th of the following month in which supply was made will be priced with next month’s claim. EREMs sent later than 180 days after the Dispense Notification was sent, will not be subject to payment; and (b) annotate the number of submitted EREMs on the appropriate claim form on the Manage Your Service (MYS) platform as per Clause 5A 6 and 717; and (c) all EPS tokens must be: (i) sorted separately from FP10 paper prescription forms with the exception of age exempt and any other tokens specified on the FP34C which must not be submitted (unless there is an exemption under Part XVI;) and (ii) dispatched in the same parcel as per Clause 5A 6 and 7. Contractors should note that EPS Tokens may be checked against claims for payment for audit purposes and possible enforcement action. The legal position is that payment will be made against the EREM, not the EPS token, and so prescription charges will be deducted, even if there is a failure to properly record an exemption that the patient can properly claim in the EREM, and if the EPS token correctly records this, unless contractors request a recheck under Part XIVB. It is a condition of entitlement to exemption from prescription charges that the patient or their representative claiming exemption must make and duly complete a declaration of entitlement unless an automatic exemption applies18. Where applicable, the contractor must ensure that the patient declaration is recorded on the system. In the case of automatic exemptions18, electronic prescriptions and paper prescriptions are similar, in that regardless of the exemption or charge information populated either by the patient/representative or the contractor, it will be disregarded (i.e. even if there is an error on the EREM, or the paper prescription states that a prescription charge was taken or if it is on a prescription with an additional chargeable item, the charge will not be deducted). 9. Claims in exceptional circumstances preventing the contractor from submitting the FP34C form as outlined in Clause 5A 6, 7 and 8. (a) In exceptional circumstances, where the contractor through no fault of their own, is unable to submit the FP34C form through the MYS portal, contractors are advised to contact the NHSBSA either through email nhsbsa.mys@nhs.net or by contacting the MYS helpdesk number (0300 330 1368). Contractors should note that this route is available only for emergencies, which are directly related to the contractor (for example internet outage in the contractor’s area) and not related to the MYS platform itself (in case of the MYS platform being down there will be instructions for contractors on the NHSBSA’s website on what to do); (b) Contractors, who will be using the email route, are advised that they must apply an advanced electronic signature to the email to secure payment; and (c) Contractors, who will be using the telephone route, are advised that the NHSBSA will contact the contractor via a preferred email address for the contractor, which the contractor has shared with them during the phone call conversation, for them to confirm that the claim the NHSBSA noted via the phone call was correct, and the contractor must apply an advanced electronic signature to the confirmation email to secure payment. 15 Pharmacy contractors should note that the Dispense Notification must be sent before the EREM. 16 Pharmacy contractors are encouraged to submit EREMs throughout the month. 17 Where one or more bank holiday occurs within the first five days of the month, dispatch must be secured by the 6th of that month. Note: The requirement to submit EREMs within the first 5 days remains unchanged. 18 This includes age exempt prescriptions, prescription forms with only free-of-charge sexual health medication and/or contraceptives, where Real Time Exemption Checking (RTEC) confirms an exemption and where a smaller quantity (in comparison with the prescription) of a drug is supplied in accordance with an SSP. 9 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS CLAUSE 5B **CALCULATION OF PAYMENTS 1. Pharmacy Contractors Payment for services provided by pharmacy contractors in respect of the supply of drugs, appliances and chemical reagents supplied against prescriptions at each separate place of business shall comprise:- (i) (a) The total of the prices of the drugs, appliances and chemical reagents so supplied calculated in accordance with the requirements of this Tariff. LESS *(b) An amount, based on the total of the prices at (i)(a) above, calculated from the table at Part V ("Deduction Scale"). AND (ii) The appropriate professional fee as set out in Part IIIA AND (iii) The allowance for consumables and containers as set out in Part IV. *NOTE 1 No deduction will be made in respect of prescriptions for items listed in Part II for which the contractor has not been able to obtain a discount. **NOTE 2 (Wales only) Payments in respect of October 1999 to March 2000. Contractors in agreement with LHBs in Wales who have notified the LHB that they accept the revised basis of calculation of payments for the period 1 October 1999 to 31 March 2000 set out in the National Assembly's offer letters on 20 November 2000 and 3 April 2001 shall be paid in accordance with the provisions of these letters. ***NOTE 3 (Wales only) Payments in respect of 1 October 2008 to 31 October 2008. Contractors in agreements with LHBs in Wales will be paid in accordance with the provisions of: Part VIA - Payment for Essential Services (Pharmacy Contractors), Part VIC - Advanced Services (Pharmacy Contractors), Medicines Use Review and Prescription Intervention Service, and Part XIII - Payments in respect of Pre Registration Trainees of the October 2008 edition of this Tariff as they apply in relation to England. 2. England only - Pharmacy Contractors - calculation of payments in exceptional circumstances (a) Calculation of payment for pharmacy contractors which submit FP34C and submit paper prescriptions after the 5th of the following month in which supply was made but before the date outlined in the following link – Pharmacy payment timetable | NHSBSA (i) Payment will be calculated as per Clause 5B1; (ii) From April 2022 (March 2022 prescriptions), the contractor will be contacted by the NHS Prescription Services for England, and unless the contractor provides evidence that the appropriate claim form was submitted as per Clause 5A 6, 7 and 8 and that the paper prescriptions were dispatched in line with Clause 5A 6, an administrative deduction of £25 will be made. This deduction reflects the administrative costs involved in NHSBSA calculating and making these payments. (iii) To prevent the administrative deduction mentioned above being made, the contractor must provide evidence, as outlined in Clause 5A 6, 7 and 8, of compliance with the submission requirements. Where evidence is submitted, no administrative deduction will be made. If no evidence is provided within this time, then the administrative deduction will be made from the next Schedule of Payment. (iv) In instances where the contractor does not provide the evidence, but the claiming process was followed as outlined in Clause 5A 6, 7 and 8, the contractor will have the opportunity to apply to have NHSBSA’s decision to make the administrative deduction mentioned in sub-paragraph (ii) above, overturned, by providing evidence and submitting it alongside an appropriate form available on NHSBSA’s website (Pharmacy payment timetable | NHSBSA). The contractor will need to submit the evidence and the appropriate form no later than one month after the month in which the administrative deduction was made. 12 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS (c) Pharmacy Earlier Payment Scheme (PEPS) (i) Pharmacy contractors, that are signed up to the Pharmacy Earlier Payment Scheme (the ‘Scheme’), should note that the Scheme will be terminated on 1 November 2021. Their last PEPS payment as outlined in Clause 5C1(c)(iii) will be paid on 1 October 2021. (ii) On 1 November 2021 a period of a 12-month transition arrangement will start for pharmacy contractors, who are signed up to PEPS, to bring them over to the timetable outlined in Clause 5C (d) or (e). As part of the transition arrangement pharmacy contractors, who are signed up to the Scheme, will receive on 1 November 2021 a one- off payment to bridge the gap between the current PEPS payment timetable and the timetable outlined in Clause 5C (d) or (e). The one-off payment will be set at 92% of the PEPS pharmacy contractor’s payment which the contractor will have received on 1 October 2021. This one-off payment will be recovered in equal parts over 11 months, i.e. the last recovery will be on 30 September 2022. PEPS pharmacy contractors, who want to opt out from the above described transition arrangements, must notify the NHSBSA of this by 15 October 2021 by emailing nhsbsa.pepscontractorpayments@nhs.net requesting to opt out. (iii) Pharmacy contractors, who are enrolled on the Scheme will receive the following payment up until October 2021: • The NHSBSA will calculate a 100% advance payment to be paid to pharmacy contractors on the 1st of the month in respect of the items they expect to dispense in that month. This calculation will be based on the average number of items over the latest available 5 months, the average item value over the latest available 12 months and the prescription charge proportion from the latest available month (i.e. the percentage amount by which that month’s payment is reduced due to prescription charges). For example, April’s advance notice will be calculated using the average number of items from September 2020 to January 2021; the average item value from February 2020 to January 2021 and the prescription charge proportion from January 2021. • Batches must be received by the 5th day of the following month after dispensing as outlined in Clause 5A 1. For example, April’s batch must be sent to the NHSBSA by the 5th May. Failure to send a batch as described above may result in the contractor being removed from the PEPS Scheme and being therefore transferred to Timetable A. • Pharmacy contractors must immediately notify the NHSBSA of any adverse or anticipated changes pertaining to the pharmacy business. • Reconciliation payment – Pharmacy contractors will be paid the reconciliation payment according to Timetable A outlined above. Table 2 This table provides an overview of payment and reconciliation that will apply for the PEPS Scheme from July 2021. * If days referred to above fall on a weekend or bank holiday, the next available working day will be applied. Dispensing month July 2021 Aug 2021 Sept 2021 Oct 2021 Advance payment* 1 July 2 Aug 1 Sept 1 Oct Reconciliation for dispensed prescriptions 1 Oct 1 Nov 1 Dec 31 Dec 13 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS England only - From November 2021 (October 2021 prescriptions)18 Pharmacy Contractors will be paid monthly via NHSBSA. Payments will be detailed in the FP34 Schedule of Payment, which pharmacy contractors will receive approximately 5 working days before payment. (d) Payment timetable for pharmacy contractors that submit their batches and where the FP34C declaration is submitted via MYS by no later than the 5th of the month following that in which the supply was made. Pharmacy contractors will receive: (i) Advance Payment – 100% advance payment for prescriptions dispensed one month earlier paid from day 8 of the month the prescriptions and the appropriate claim form are submitted for pricing as per Clause 5A 6, 7 and 8 (see Table 3 below). This payment is based on the total items declared on the FP34C submission document and the latest available average Net Ingredient Cost (NIC) for that pharmacy, less the value of prescription charges collected and declared on the FP34C submission document. Formula for calculating estimated advance payment: Average Net Ingredient Cost of the prescriptions * x number of items declared on the submission document less the value of prescription charges declared as collected at the rate payable on the date of dispensing. (ii) Reconciliation Payment – • Positive reconciliation – pharmacy contractors will be paid the reconciliation payment on the 1st working day of the month two months after they have submitted the appropriate claim form and prescriptions for pricing. • Negative reconciliation – NHSBSA will recover the value of the overestimate from the 100% advance payment paid circa 6 working days later than the positive reconciliation (for exact dates see Table 3 below). Table 3 Payment timetable - From November 2021 (October 2021 prescriptions) for submissions made via MYS *Note - Where one or more bank holiday occurs within the first five days of the month, dispatch / submission must be secured by the 6th of that month. As a consequence, this will have an impact on the payment date, i.e. it will be 4 working days from the submission / dispatch date deadline. **Negative reconciliation will be recovered from the next advance payment due. 18 Pharmacy contractors should note that until March 2022 two systems will be run concurrently – for those pharmacy contractors who wish to continue to use paper FP34C and receive payment as per Clause 5C1(a) and for those who wish to use MYS platform to populate their FP34C and receive payment as per Clause 5C1(d). From April 2022, only the timetable outlined in Clause 5C1(d) will be in place (i.e. all pharmacy contractors will have to use MYS). Advance for dispensed prescriptions Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Planned advance payment date (4 working days after the submission/ dispatch deadline*) 11 Nov 21 9 Dec 21 11 Jan 22 10 Feb 22 10 Mar 22 11 Apr 22 11 May 22 9 Jun 22 11 Jul 22 11 Aug 22 9 Sep 22 11 Oct 22 10 Nov 22 9 Dec 22 11 Jan 23 9 Feb 23 9 Mar 23 Reconciliation month for dispensed prescriptions Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan ** Pay date for reconciled prescriptions - Payment due 1 Dec 21 31 Dec 21 1 Feb 22 1 Mar 22 1 Apr 22 29 Apr 22 1 Jun 22 1 Jul 22 1 Aug 22 1 Sep 22 30 Sep 22 1 Nov 22 1 Dec 22 30 Dec 22 1 Feb 23 1 Mar 23 3 Apr 23 14 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS (e) Payment timetable in exceptional circumstances (i) Payment timetable for pharmacy contractors that submit their batches after the 5th of the following month in which supply was made but before the date outlined in the following link – Pharmacy payment timetable | NHSBSA: Payments will be made monthly and comprise of the following elements: 1. An estimated 100% advance payment for prescriptions submitted one month earlier (dispensed two months earlier). This payment is based on the total items declared on the FP34C submission document and the latest available average Net Ingredient Cost (NIC) for that pharmacy, less the value of prescription charges collected and declared on the FP34C submission document; Formula for calculating estimated advance payment Average Net Ingredient Cost of the prescriptions * x number of items declared on the submission document less the value of the prescription charges declared as collected at the rate payable on the date of dispensing 2. plus the full value of the priced prescriptions submitted two months earlier (dispensed three months earlier); 3. minus the recovery of the estimated 100% advance payment paid the previous month related to the prescriptions submitted two months earlier (dispensed three months earlier). For example, August’s payment will comprise the 100% advance payment for prescriptions submitted in July (dispensed in June) with the full value of the priced prescriptions less the recovery of the estimated 100% advance payment for prescriptions submitted in June (dispensed in May). Table 4 Payment timetable in exceptional circumstances - From November 2021 (October 2021 prescriptions) (ii) Payment timetable for pharmacy contractors that submitted their batches after the date outlined in the following link - Pharmacy payment timetable | NHSBSA. Pharmacy contractors will receive payment with the next reconciliation payment (i.e. there will be no advance payment). For example: Example 1 - for prescriptions dispensed in November if the FP34C was submitted on 29 December, the pharmacy contractor would not receive the advance payment for November’s prescriptions on 1 January instead they would receive the reconciliation payment for November’s prescriptions on 1 February. Example 2 – for prescriptions dispensed in November if the paper prescriptions arrive at the NHSBSA on 29 December the pharmacy contractor would receive payment for these paper prescriptions according to the payment timetable for the reconciliation payment for December’s prescriptions i.e. on 1 March. Advance for dispensed prescriptions Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Planned advance payment date 1 Dec 21 31 Dec 21 1 Feb 22 1 Mar 22 1 Apr 22 29 Apr 22 1 Jun 22 1 Jul 22 1 Aug 22 1 Sep 22 30 Sep 22 1 Nov 22 1 Dec 22 30 Dec 22 1 Feb 23 1 Mar 23 3 Apr 23 Reconciliation month for dispensed prescriptions Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Pay date for reconciled prescriptions - Payment due 1 Dec 21 31 Dec 21 1 Feb 22 1 Mar 22 1 Apr 22 29 Apr 22 1 Jun 22 1 Jul 22 1 Aug 22 1 Sep 22 30 Sep 22 1 Nov 22 1 Dec 22 30 Dec 22 1 Feb 23 1 Mar 23 3 Apr 23 17 04/2022 Part I REQUIREMENTS FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Table 2 Table 3 Pharmacy opened in May and submitted FP34C for May Pharmacy opened in May and did not submit FP34C for May but did so in June How the uplift should be calculated for the pharmacy? Must get the average each prescription got from £50 million for each prescription they dispensed in May. No uplift. However, the pharmacy contractor can demonstrate whether they provided NHS pharmaceutical services in May but failed to submit the batch so it could be considered whether they should access the uplift based on £50 million (see the reference to the appropriate form above). Pharmacy opened in June and submitted FP34C for June Pharmacy opened in June and did not submit FP34C for June but did so in July How the uplift should be calculated for the pharmacy? Must get the average each prescription got from £20 million for each prescription they dispensed in June. No uplift. However, the pharmacy contractor can demonstrate whether they provided NHS pharmaceutical services in June but failed to submit the batch so it could be considered whether they should access the uplift based on £20 million (see the reference to the appropriate form above). 18 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Part II - Requirements Enabling Payments to be made for the supply of Drugs, Appliances and Chemical Reagents CLAUSE 6 INFORMATION RELATING TO THE IDENTIFICATION OF THE PRESCRIBER Where a contractor provides the drugs or appliances ordered on any NHS prescription form, except forms issued by a Dental Practitioner, the Pricing Authority may return the prescription form to the contractor (as a referred back) if there is no prescriber code(s) present on the prescription form and request that the contractor seek the appropriate code(s). Where the contractor is able to identify the appropriate code(s), they shall endorse the prescription with the code and return it to the Pricing Authority. Where the contractor is unable to identify the appropriate code(s), they shall endorse the prescription to indicate that they have been unable to locate the code and return it to the Pricing Authority to be paid. Returned prescriptions shall be priced using the Drug Tariff relevant to the month in which the prescription is returned to the Pricing Authority. CLAUSE 7 PAYMENTS FOR DRUGS, APPLIANCES AND CHEMICAL REAGENTS A The price on which payment is based for a quantity of a drug, appliance or chemical reagent supplied is calculated proportionately from the basic price (see Clause 8 - Basic Price). B Subject to the provisions of Clause 10 (Quantity to be supplied) payment will be calculated on the basis that the exact quantity ordered by the prescriber has been supplied, apart from any supply made under a Serious Shortage Protocol (SSP) for a reduced or increased quantity. C Where a prescription form has been returned to the contractor for endorsement or elucidation and it is returned to the Pricing Authority unendorsed, or incompletely endorsed, or without further explanation, then the price for the drug, appliance or chemical reagent which it orders shall be determined by the Secretary of State for Health and Social Care and the Welsh Ministers. CLAUSE 8 BASIC PRICE A The basic price for those drugs, appliances and chemical reagents ordered by a name, or a synonym of that name, included in Parts VIII or IX shall be the price listed in the Drug Tariff. B In exceptional circumstances, where, in the opinion of the Secretary of State for Health and Social Care and the Welsh Ministers, there is no product available to contractors, at the price in Part VIII, claims for reimbursement for a product with a higher price than that listed may be accepted. Such claims shall be made by endorsement as set out in Clause 9C but only in the circumstances described in that Clause. If the Secretary of State for Health and Social Care and the Welsh Ministers are satisfied that the contractor was not able reasonably to obtain the product at a lower price, the basic price shall be the list price, for supplying to contractors, of the product and pack size so used, or such other price as the Secretary of State for Health and Social Care and the Welsh Ministers shall determine. The Secretary of State for Health and Social Care and the Welsh Ministers will publish details of any preparations to which this applies and the month(s) in which it applies. The Secretary of State for Health and Social Care and the Welsh Ministers may in addition specify the products for which endorsement will be accepted. C The basic price for a drug which is not listed in Part VIII of the Tariff shall be the list price, for supplying to contractors, of the pack size to be used for a prescription for that quantity, published by the manufacturer, wholesaler or supplier. In default of any such list price, the price shall be determined by the Secretary of State for Health and Social Care and the Welsh Ministers. D For SSP reimbursement and remuneration, refer to Clause 14. CLAUSE 9 ENDORSEMENT REQUIREMENTS A Contractors shall endorse prescription forms for drugs, appliances and chemical reagents listed in this Tariff as required by this Clause and when so required by the provisions of Part II Clauses 10 (Quantity to be Supplied) and 11 (Broken Bulk), Part III (Fees), Notes to Part VIIIB, Notes to Part VIIID and Note 2 to Part IXA/B/C (Appliances). B Prescriptions for drugs not listed in Part VIII of the Tariff shall be endorsed by the contractor with the pack size from which the order was supplied and, if the order is in pharmacopoeial or 'generic' form, with the brand name or the name of the manufacturer or wholesaler from whom the supply was purchased. Where the preparation is in Part VIIIA of the Tariff, endorsement of pack size is not necessary except for products in Category C that have more than one pack size listed. Where additional specific endorsement is necessary, contractors shall endorse prescription forms when so required by the provisions of Part II Clauses 10 (Quantity to be Supplied) and 11 (Broken Bulk), Part III (Fees) and Notes to Part VIIIB and Part VIIID. 19 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS C Where the preparation is in Part VIII of the Tariff and, as described in Clause 8B, in the opinion of the Secretary of State for Health and Social Care and the Welsh Ministers there is no product available to contractors at the appropriate price, endorsements of brand name or of manufacturer or wholesaler of the product and pack size so used may be accepted. Contractors shall not so endorse unless they have made all reasonable efforts to obtain the product at the appropriate price but have not succeeded. The endorsement shall be initialled and dated by or on behalf of the contractor, and shall be further endorsed "no cheaper stock obtainable" or "NCSO" to indicate that the contractor has taken all such responsible steps. D Where a contractor supplies a quantity at variance with that ordered. i.e. under the provisions set out in Clause 10 (Quantity to be Supplied), the prescription shall be endorsed with the quantity supplied. E From February 2022 (i.e. for February’s prescriptions claimed by 5 March), where a contractor supplies a product in accordance with a single dispensed product SSP (where a prescribed product is replaced by one product), the contractor must, in respect of - a non - electronic prescription forms - endorse the prescription form with “SSP” and the three- digit reference number of the specific SSP to indicate that a supply was made in accordance with a SSP, in addition to any other information required under Clause 9 (apart from Clause 9C); and b electronic prescription forms - pharmacy contractors must indicate that a supply was made in accordance with a SSP on the Electronic Reimbursement Endorsement Message (EREM) by selecting “SSP”, entering the three-digit reference number of the specific SSP and endorsing the appropriate dispensed product and quantity, in addition to any other information required under Clause 9 (apart from Clause 9C). From February 2022, where a contractor supplies a product in accordance with a multiple dispensed product SSP (where a prescribed product is replaced by two or more products), the contractor must, in respect of - c non - electronic prescription forms - endorse the prescription form with “SSP” and the three- digit reference number of the specific SSP to indicate that a supply was made in accordance with a SSP, in addition to any other information required under Clause 9 (apart from Clause 9C) for all products supplied under the SSP; and d electronic prescription forms - pharmacy contractors must indicate that a supply was made in accordance with a SSP on the EREM by selecting “SSP”, entering the three-digit reference number of the specific SSP endorsing the appropriate dispensed products and quantities, in addition to any other information required under Clause 9 (apart from Clause 9C), for each of the products dispensed under that SSP. Where the endorsement functionality does not allow for all replacement products to be endorsed, contractors should endorse by selecting “SSP” and entering the three-digit reference number of the specific SSP, in addition to any other information as required under Clause 9 (apart from Clause 9C), for only one product (in the event that a non-Part VIII product is one of the replacement SSP products, this product must be the one endorsed in accordance with Clause 9 - apart from Clause 9C). The Pricing Authority for England will reimburse pharmacy contractors for the remaining products in the SSP. F Where insufficient information is available to enable the Pricing Authority to process the prescription, including where it was submitted for a SSP payment, the form (or a copy of the original form) shall be returned to the contractor who shall endorse the prescription form (or copy) with the information requested. Returned prescriptions shall be priced using the Drug Tariff relevant to the month in which the prescription form (or copy) is returned to the Pricing Authority. CLAUSE 10 QUANTITY TO BE SUPPLIED A Subject to the requirements of the Weights and Measures (Equivalents for Dealing with Drugs) Regulations, 1970, with regard to the supply in metric quantities of orders expressed in imperial quantities, payment will normally be calculated on the basis that the exact quantity ordered by the prescriber has been supplied, except only in the case of a SSP, and of those preparations referred to in B below: 22 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Contractors who have not received discount in respect of the following products need not endorse the prescription. The prescription price reimbursement will have no discount deduction applied. GROUP ITEMS Cold Chain Storage (ALL) Controlled Drugs in schedules 1, 2 and 3 of the Misuse of Drugs Regulations 2001 Cytotoxic or Cytostatic items (ALL) Immunoglobulins (ALL) Insulins for Injection (ALL) Vaccines and Antisera (ALL) Unlicensed medicines not listed in Part VIIIB where the product has been sourced from a supplier holding a MHRA specials or importers licence (prescriptions must be endorsed with invoice price less discount/rebate) INDIVIDUAL ITEMS Abilify Maintena 400mg powder and solvent for prolonged-release suspension for injection pre-filled syringes Abilify Maintena 400mg powder and solvent for prolonged-release suspension for injection vials Acetic acid 33% liquid Acetic acid dilute 420microlitres/5ml oral solution sugar free Acetic acid glacial Acetone liquid Acetylcysteine 2g/10ml solution for infusion ampoules Acetylsalicylic acid (Aspirin powder) powder Aciclovir 200mg/5ml oral suspension sugar free Aciclovir 400mg/5ml oral suspension sugar free Acitretin 25mg capsules Aclasta 5mg/100ml infusion bottles Acumor XL 16mg capsules Acumor XL 24mg capsules A-CYS 600mg capsules A-CYS 600mg effervescent tablets A-CYS 600mg tablets Adartrel 2mg tablets Adcirca 20mg tablets Adefovir 10mg tablets Adempas tablets (ALL) Adoport capsules (ALL) Adrenaline (base) (1 in 10,000) dilute solution for injections ampoules (ALL) Adrenaline (base) 10mg/10ml (1 in 1,000) solution for injection ampoules Adrenaline (base) 5mg/5ml (1 in 1,000) solution for injection ampoules Adrenaline (base) solution for injection pre-filled disposable devices (ALL) Advagraf 1mg modified-release capsules Advagraf 3mg modified-release capsules Advagraf 5mg modified-release capsules Albunorm 5% solution for infusion 100ml bottles Aldara 5% cream 250mg sachets Alimemazine 10mg tablets Alimemazine 30mg/5ml oral solution Alimemazine 30mg/5ml oral solution sugar free Alimemazine 7.5mg/5ml oral solution Alimemazine 7.5mg/5ml oral solution sugar free Alimentum powder Alitretinoin capsules (ALL) Alkindi granules in capsules for opening (ALL) Almuriva 4.6mg/24hours transdermal patches Alpro Organic Soya Original milk Alpro Organic Soya Wholebean Unsweetened milk Alprostadil 20microgram powder and solvent for solution for injection cartridges Alprostadil 40microgram powder and solvent for solution for injection cartridges Alprostadil 20microgram powder and solvent for solution for injection vials Altraplen Compact Starter Pack liquid 23 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Altraplen Protein liquid Altraplen Protein Starter Pack liquid Altrashot 120ml bottles Altrashot Starter Pack liquid Ambrisentan tablets (ALL) Amiloride 5mg/5ml oral solution sugar free Aminophylline 250mg/10ml solution for injection ampoules Ammonaps 500mg tablets Ammonaps 940mg/g granules Ammonia solution strong Ammonium bicarbonate powder Ammonium chloride powder Ampicillin 500mg powder for solution for injection vials Anise water concentrated Anquil 250microgram tablets APO-go PEN 30mg/3ml solution for injection APO-go PFS 50mg/10ml solution for infusion pre-filled syringes APO-go 50mg/5ml solution for injection ampoules Apomorphine 100mg/20ml solution for infusion vials Apomorphine 30mg/3ml solution for injection cartridges Apomorphine 30mg/3ml solution for injection pre-filled disposable devices Apomorphine 50mg/10ml solution for infusion pre-filled syringes Apomorphine 50mg/5ml solution for injection ampoules Apraclonidine 1% eye drops 0.25ml unit dose preservative free Apremilast 30mg tablets Aprepitant 125mg capsules and Aprepitant 80mg capsules Aptamil Pepti 1 powder Aptamil Pepti 2 powder Aptamil Pepti-Junior powder Arachis oil 130ml enema Arava 10mg tablets Arava 20mg tablets Arimidex 1mg tablets Aripiprazole 1mg/1ml oral solution sugar free Aripiprazole 400mg powder and solvent for suspension for injection pre-filled syringes Aripiprazole 400mg powder and solvent for suspension for injection vials Arixtra solution for injection pre-filled syringes (ALL) Arnica tincture Aromasin 25mg tablets Arpoya 10mg tablets Arpoya 5mg tablets Aspirin suppositories (ALL) Atomoxetine 4mg/ml oral solution sugar free Atomoxetine capsules (ALL) Atovaquone 750mg/5ml oral suspension sugar free Atripla 600mg/200mg/245mg tablets Atropine 1% eye drops Atropine 1mg/1ml solution for injection ampoules Atropine 3mg/10ml solution for injection pre-filled syringes Aubagio 14mg tablets Aymes ActaSolve High Energy powder 85g sachets Aymes ActaSolve High Energy Starter Pack powder Azilect 1mg tablets Baraclude tablets (ALL) Baraclude 0.05mg/ml oral solution Baricitinib tablets (ALL) Basecal200 oral powder 43g sachets Beclometasone 0.025% cream Beclometasone 0.025% ointment Beclometasone 5mg gastro-resistant modified-release tablets Benperidol 250microgram tablets 24 Part II 04/2022 REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Benzocaine powder Benzoic acid powder Benzoin compound tincture Benzoin tincture Benzyl benzoate 25% application Benzyl benzoate crystals Berinert 500unit powder and solvent for solution for injection vials Betaferon 300microgram powder and solvent for solution for injection vials Betaine oral powder Betaloc I.V. 5mg/5ml solution for injection ampoules Betamethasone valerate 0.1% / Clioquinol 3% cream Betamethasone valerate 0.1% / Clioquinol 3% ointment Betamethasone valerate 0.1% / Neomycin 0.5% cream Betamethasone valerate 0.1% / Neomycin 0.5% ointment Betaquik liquid Biktarvy 50mg/200mg/25mg tablets Bismuth subnitrate powder Borax powder Boric Acid powder Bramox 10mg tablets Bramox 5mg tablets Branched-Chain Amino Acid Module powder Bricanyl 2.5mg/5ml solution for injection ampoules Brivaracetam 100mg tablets Brivaracetam 25mg tablets Brivaracetam 50mg tablets Brivaracetam 50mg/5ml oral solution sugar free Brivaracetam 75mg tablets Briviact 100mg tablets Briviact 10mg/ml oral solution Briviact 25mg tablets Briviact 50mg tablets Briviact 75mg tablets Bromocriptine 2.5mg tablets Bronchitol 40mg inhalation powder capsules with two devices Budenofalk 3mg gastro-resistant capsules Budenofalk 9mg gastro-resistant granules sachets Budesonide 1mg orodispersible tablets sugar free Budesonide 1mg/2ml nebuliser liquid unit dose vials Budesonide 2mg/100ml enema Budesonide 3mg gastro-resistant capsules Budesonide 500micrograms/2ml nebuliser liquid unit dose vials Budesonide 9mg gastro-resistant granules sachets Budesonide 9mg modified-release tablets Bumetanide 1mg/5ml oral solution sugar free Buserelin nasal spray (ALL) Cabaser 1mg tablets Cabaser 2mg tablets Caffeine citrate powder Calamine and coal tar ointment Calcipotriol 50micrograms/ml scalp solution Calcium polystyrene sulfonate powder sugar free Calcium Resonium powder Calogen emulsion Calogen Extra emulsion Calogen Extra Shots emulsion Camellia sinensis extract 10% ointment Camphor racemic powder Camphor water concentrated Capexion 0.5mg capsules Capimune 100mg capsules 27 Part II 04/2022 REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Dicycloverine tablets (ALL) Dicycloverine 10mg/5ml oral solution Diethylstilbestrol 1mg tablets Dificlir 200mg tablets Diflucan 200mg capsules Diflucan 200mg/5ml oral suspension Dipyridamole 50mg/5ml oral suspension sugar free Dithranol powder DocOmega oral powder 4g sachets Docusate 120mg/10g enema Dolutegravir tablets (ALL) Domperidone 1mg/ml oral suspension sugar free Donepezil 1mg/ml oral solution sugar free Donepezil orodispersible tablets (ALL) Dovato 50mg/300mg tablets Doxepin 25mg capsules Doxepin 50mg capsules Doxylamine 10mg / Pyridoxine 10mg gastro-resistant tablets Dronedarone 400mg tablets Duocal Super Soluble powder Dynastat 40mg powder and solvent for solution for injection vials Dynastat 40mg powder for solution for injection vials EAA Supplement oral powder 12.5g sachets Easiphen liquid E-Caps 200unit capsules E-Caps 400unit capsules Edurant 25mg tablets EleCare powder Elemental 028 Extra liquid Elemental 028 Extra powder Elive Cod Liver Oil 1000mg capsules Elmino XL 16mg capsules Elmiron 100mg capsules Eltrombopag tablets (ALL) Emend 125mg and 80mg capsules Emend 125mg oral powder sachets Emerade (1 in 1,000) solution for injection auto-injectors (ALL) Emsogen powder Emtricitabine / Tenofovir alafenamide tablets (ALL) Energivit powder Enoxaparin sodium 40mg/0.4ml solution for injection pre-filled syringes Enoxaparin sodium 60mg/0.6ml solution for injection pre-filled syringes Enoxaparin sodium 80mg/0.8ml solution for injection pre-filled syringes Enoxaparin sodium 100mg/1ml solution for injection pre-filled syringes Enoxaparin sodium 120mg/0.8ml solution for injection pre-filled syringes Enoxaparin sodium 150mg/1ml solution for injection pre-filled syringes Enoxaparin sodium 300mg/3ml solution for injection vials EN-Selenium 200microgram tablets Enshake oral powder 96.5g sachets Ensure Compact liquid Ensure liquid Ensure Plus Advance liquid Ensure Plus Commence liquid Ensure Plus Creme Ensure Plus Fibre liquid Ensure Plus Juce liquid Ensure TwoCal liquid EN-Taurine 500mg capsules Entecavir 50micrograms/ml oral solution sugar free Entocort 2mg/100ml enema Entresto tablets (ALL) 28 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Enzalutamide 40mg capsules Epclusa 400mg/100mg tablets Epilim Chronosphere MR 100mg granules sachets Epilim Chronosphere MR 250mg granules sachets Epilim Chronosphere MR 500mg granules sachets Epilim Chronosphere MR 50mg granules sachets Epilim Intravenous 400mg powder and solvent for solution for injection vials EpiPen 300micrograms/0.3ml (1 in 1,000) solution for injection auto-injectors EpiPen Jr. 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors Episenta 300mg/3ml solution for injection ampoules Epivir tablets (ALL) Erastig 13.3mg/24hours transdermal patches Erythromycin 1g powder for solution for infusion vials Esbriet 267mg capsules Esbriet tablets (ALL) Esmya 5mg tablets Essential Amino Acid Mix powder Ethanol 70% duty paid Ethanol 90% including duty Ethanol Absolute Duty Paid Ethosuximide 250mg capsules Ethosuximide 250mg/5ml oral solution sugar free Ether solvent Ethinylestradiol 10microgram tablets Ethinylestradiol 1mg tablets Ethinylestradiol 50microgram tablets Etonogestrel 68mg implant Eucalyptus oil liquid Eviplera 200mg/25mg/245mg tablets Evotaz 300mg/150mg tablets Exjade tablets (ALL) Extavia 300microgram powder and solvent for solution for injection vials Famciclovir 250mg tablets Famciclovir 500mg tablets Fampyra 10mg modified-release tablets Famvir 125mg tablets Fareston 60mg tablets Femara 2.5mg tablets Feraccru 30mg capsules Ferinject solution for injection vials (ALL) Ferric chloride solution Ferric maltol (iron 30mg) capsules Ferriprox 1000mg tablets Ferrous sulfate heptahydrate powder Fidaxomicin 200mg tablets Fingolimod 500microgram capsules Firdapse 10mg tablets Firmagon powder and solvent for solution for injection vials (ALL) Flexible collodion methylated Flixotide Nebules (ALL) Flixotide 500micrograms/dose Accuhaler Flucloxacillin 1g powder for solution for injection vials Flucloxacillin 500mg powder for solution for injection vials Fluconazole 200mg/5ml oral suspension Fluconazole 200mg/100ml solution for infusion vials Fluoxetine 10mg capsules Fluticasone 250micrograms/dose / Formoterol 10micrograms/dose inhaler CFC free Fluticasone nebuliser liquid unit dose vials (ALL) Fluticasone propionate 500micrograms/dose dry powder inhaler Flutiform 250micrograms/dose / 10micrograms/dose inhaler Folic acid 5mg/5ml oral solution sugar free 29 Part II 04/2022 REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Follitropin alfa 75unit powder and solvent for solution for injection vials Follitropin alfa 450unit powder and solvent for solution for injection vials Fondaparinux sodium solution for injection pre-filled syringes (ALL) Formaldehyde solution Forticare liquid Forticreme Complete dessert Fortijuce liquid Fortini 1.0 Multi Fibre liquid Fortini Compact Multi Fibre liquid Fortini Creamy Fruit Multi Fibre Fortini liquid Fortini Multi Fibre liquid Fortini Smoothie Multi Fibre liquid Fortisip 2kcal liquid Fortisip Compact Fibre liquid Fortisip Compact Fibre Starter Pack liquid Fortisip Compact Protein liquid Fortisip Compact Protein Starter Pack liquid Fortisip Compact Starter Pack liquid Fortisip Extra liquid Fortisip Yogurt Style liquid Fortum 1g powder for solution for injection vials Fortum 2g powder for solution for injection vials Fosrenol chewable tablets (ALL) Fosrenol oral powder sachets (ALL) Fostimon 150unit powder and solvent for solution for injection vials Fragmin 10,000units/0.4ml solution for injection pre-filled syringes Fragmin 100,000units/4ml solution for injection vials Fragmin 12,500units/0.5ml solution for injection pre-filled syringes Fragmin 15,000units/0.6ml solution for injection pre-filled syringes Fragmin 18,000units/0.72ml solution for injection pre-filled syringes Fragmin 5,000units/0.2ml solution for injection pre-filled syringes Fragmin 7,500units/0.3ml solution for injection pre-filled syringes Fragmin Graduated Syringe 10,000units/1ml solution for injection pre-filled syringes Fragmin solution for injection ampoules (ALL) Frebini Energy Drink Frebini Energy Fibre liquid Frebini Energy Fibre liquid unflavoured Frebini Energy liquid Frebini Original Fibre liquid Frebini Original liquid FreeStyle Libre Sensor FreeStyle Libre 2 Sensor Fresubin 1000 Complete liquid Fresubin 1200 Complete liquid Fresubin 1500 Complete liquid Fresubin 1800 Complete liquid Fresubin 2250 Complete liquid Fresubin 2kcal Fibre drink Fresubin 5kcal shot drink Fresubin Energy Fibre liquid Fresubin Energy liquid unflavoured Fresubin HP Energy liquid Fresubin Original Fibre liquid Fresubin Original liquid unflavoured Fresubin Soya Fibre liquid Fresubin Thickened Level 2 Fresubin Thickened Level 3 FruitiVits oral powder 6g sachets Furosemide 250mg/25ml solution for injection ampoules GA amino5 oral powder 6g sachets 32 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Jevity liquid Jevity Plus liquid Jevity Plus HP gluten free liquid Jevity Promote liquid Jext solution for injection auto-injectors (ALL) Jorveza 1mg orodispersible tablets Jyseleca tablets (ALL) Kalydeco 150mg tablets Keppra 100mg/ml oral solution Keppra 500mg/5ml concentrate for solution for infusion vials Keppra 1g tablets Keppra 500mg tablets Keppra 750mg tablets KetoCal 2.5:1LQ liquid KetoCal 3:1 powder KetoCal 4:1 powder KetoCal 4:1 LQ liquid KetoClassic 3:1 Breakfast porridge KetoClassic 3:1 Meal bolognese 126g pouches KetoClassic 3:1 Meal chicken 135g pouches KetoClassic 3:1 Savoury meal Ketoconazole 200mg tablets KetoVie 4:1 liquid KeyOmega oral powder 4g sachets K.Yo semi-solid food 100g pots Kigabeq soluble tablets (ALL) Kindergen powder Kivexa 600mg/300mg tablets Klaricid IV 500mg powder for solution for infusion vials L-Arginine powder (Nutricia Ltd) Lacosamide 150mg tablets Lacosamide 200mg tablets Lactic acid liquid Lamictal dispersible tablets (ALL) Lamictal 100mg tablets Lamictal 200mg tablets Lamivudine tablets (ALL) Lamotrigine 2mg dispersible tablets sugar free Lanthanum carbonate chewable tablets (ALL) Lanthanum carbonate oral powder sachets (ALL) Larve Lavender oil liquid Leflunomide 15mg tablets Lemon spirit Lenalidomide 10mg capsules Lenalidomide 25mg capsules Lenalidomide 5mg capsules Lenalidomide 7.5mg capsules Lenograstim powder and solvent for solution for injection pre-filled syringes (ALL) Leucine100 oral powder sachets Leuprorelin 11.25mg powder and solvent for suspension for injection pre-filled syringes Levetiracetam 1g granules sachets sugar free Levetiracetam 100mg/ml oral solution sugar free Levetiracetam 500mg granules sachets sugar free Levetiracetam 500mg/5ml solution for infusion ampoules Levetiracetam 500mg/5ml solution for infusion vials Levocarnitine 1g chewable tablets Levocarnitine 1.5g/5ml oral solution paediatric Levomepromazine 6mg tablets Levonorgestrel 13.5mg intrauterine device Levonorgestrel 20micrograms/24hours intrauterine device 33 Part II 04/2022 REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Levosert 20micrograms/24hours intrauterine device Levothyroxine sodium 100micrograms/5ml oral solution sugar free Levothyroxine sodium 125micrograms/5ml oral solution sugar free Linezolid 100mg/5ml oral suspension Linezolid 600mg tablets Liothyronine 10microgram tablets Liothyronine 20microgram tablets Liothyronine 5microgram tablets Lipistart powder Liquigen emulsion Lisinopril 5mg/5ml oral solution sugar free Lithium carbonate 250mg tablets Locasol powder Lofepramine 70mg/5ml oral suspension sugar free Lokelma oral powder sachets (ALL) Lophlex powder 27.8g sachets Loprofin SNO-PRO drink Lorenzo’s oil Lotprosin XL capsules (ALL) Magenta powder Magstar 160mg capsules Malarivon 80mg/5ml syrup Malarone 250mg/100mg tablets Mannitol 40mg inhalation powder capsules with two devices Mastic compound paste Maraviroc tablets (ALL) Maviret 100mg/40mg tablets MCTprocal oral powder 16g sachets Mebeverine 50mg/5ml oral suspension sugar free Medrone 100mg tablets Medroxyprogesterone 400mg tablets Mefenamic acid 50mg/5ml oral suspension Meglumine amidotrizoate 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free Melatonin 1mg/ml oral solution sugar free Melatonin 2mg capsules Melatonin 3mg capsules Melatonin 5mg capsules Melatonin 5mg modified-release tablets Memantine 10mg/ml oral solution sugar free Menadiol 10mg tablets Menopur 75unit powder and solvent for solution for injection vials Menopur 150unit powder and solvent for solution for injection vials Menthol crystals Merional powder and solvent for solution for injection vials (ALL) Mercaptamine 150mg capsules Mercaptamine 50mg capsules Meronem powder for solution for injection vials (ALL) Mesalazine 1g/application foam enema Mesalazine 1g gastro-resistant tablets Mesalazine 1.6mg gastro-resistant tablets Mesalazine 400mg gastro-resistant tablets Mesalazine 800mg gastro-resistant tablets Metformin 500mg/5ml oral solution sugar free Methyl salicylate 25% liniment Methyl salicylate 50% ointment Methyldopa 125mg tablets Methylnaltrexone bromide 12mg/0.6ml solution for injection vials Methylprednisolone 100mg tablets Methylprednisolone sodium succinate 1g powder and solvent for solution for injection vials Metyrapone 250mg capsules Metoclopramide 5mg/5ml oral solution sugar free 34 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Metopirone 250mg capsules Midodrine 10mg tablets Midodrine 5mg tablets Mimpara tablets (ALL) Mineralised methylated spirit Mirena 20micrograms/24hours intrauterine device Mirtazapine 15mg/ml oral solution sugar free Misoprostol 400microgram tablets MMA / PA Anamix Junior oral powder 18g sachets MMA / PA amino5 oral powder 6g sachets Modafinil tablets (ALL) Modigraf granules sachets (ALL) Modisal XL 40mg tablets Modulen IBD powder Monogen powder Moxisylyte 40mg tablets MSUD Aid 111 powder MSUD amino5 oral powder 6g sachets MSUD Anamix Infant powder MSUD Anamix Junior LQ liquid MSUD Anamix Junior oral powder sachets MSUD cooler liquid MSUD express15 oral powder 25g sachets MSUD express20 oral powder 34g sachets MSUD gel 24g sachets MSUD Lophlex LQ 20 liquid MSUD Maxamum powder Multaq 400mg tablets Mycobutin 150mg capsules Mycophenolate mofetil 1g/5ml oral suspension sugar free Mycophenolic acid 360mg gastro-resistant tablets Myfenax 250mg capsules Myfenax 500mg tablets Myfortic gastro-resistant tablets (ALL) Nafarelin 200micrograms/dose nasal spray Nalcrom 100mg capsules Nebido 1000mg/4ml solution for injection vials Nebivolol 2.5mg tablets Nemdatine 20mg tablets Neocate Advance powder Neocate Junior powder Neocate LCP powder Neocate Spoon powder Neocate Syneo powder Neostigmine 15mg tablets Neotigason 25mg capsules Nepro HP liquid Neupro transdermal patches (ALL) Nexplanon 68mg implant Nifedipine 10mg capsules Nitrazepam 2.5mg/5ml oral suspension Nitrofurantoin 25mg/5ml oral suspension sugar free Norgalax 120mg/10g enema Nortriptyline 50mg tablets Noxafil 40mg/ml oral suspension Noxafil 100mg gastro-resistant tablets Noyada oral solution (ALL) Nutilis Complete Creme Level 3 custard Nutilis Complete Drink Level 3 liquid Nutilis Fruit Dessert Level 4 Nutramigen 1 with LGG powder Nutramigen 2 with LGG powder 37 Part II 04/2022 REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted PKU cooler20 liquid PKU Easy microtabs PKU Easy Shake & Go oral powder 34g sachets PKU explore10 oral powder 25g sachets PKU explore5 oral powder 12.5g sachets PKU express plus15 powder PKU express plus20 powder PKU gel powder PKU GMPro oral powder 33.3g sachets PKU Lophlex powder 28g sachets PKU Lophlex LQ 10 liquid PKU Lophlex LQ 20 liquid PKU Lophlex Sensation 20 PKU Maxamum oral powder sachets PKU Maxamum powder PKU sphere15 oral powder PKU sphere20 oral powder 35g sachets PKU squeezie liquid 85g pouches PKU start powder PKU Synergy oral powder 33g sachets Plenadren 5mg modified-release tablets Podophyllum resin powder Polyfusor SB sodium chloride 0.45% infusion 500ml bottles Polyfusor W water for injection bottles (ALL) Posaconazole 100mg gastro-resistant tablets Posaconazole 40mg/ml oral suspension Potassium chloride 15% (potassium 20mmol/10ml) solution for infusion 10ml ampoules Potassium iodide powder Potassium permanganate powder Pradaxa 150mg capsules Pradaxa 75mg capsules Pramipexole 350microgram tablets Prednisolone 20mg/application foam enema Pregestimil LIPIL powder Prezista 100mg/ml oral suspension Prezista 800mg tablets Primidone tablets (ALL) Pro-Cal shot Pro-Cal shot starter pack Proflavine hemisulfate powder Prograf capsules (ALL) Proguanil 100mg / Atovaquone 250mg tablets Promazine 25mg/5ml oral solution Promazine 50mg/5ml oral solution Prometax 4.6mg/24hours transdermal patches Propranolol oral solution sugar free (ALL) Propylthiouracil 50mg tablets ProSource liquid 30ml sachets ProSource jelly ProSource Plus liquid 30ml sachets Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes ProSure liquid Provera 400mg tablets ProZero liquid Psytixol 200mg/1ml solution for injection ampoules Pulmocare liquid Pyrid-10 tablets Pyrid-20 tablets Qtern 5mg/10mg tablets Quetiapine 300mg modified-release tablets Quetiapine 400mg modified-release tablets 38 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Quinagolide 75microgram tablets Qutenza 179mg cutaneous patches Ralnea XL 4mg tablets Ralnea XL 8mg tablets Raltegravir 400mg tablets Rapamune tablets (ALL) Raponer XL 8mg tablets Raxone 150mg tablets Relistor 12mg/0.6ml solution for injection vials Renagel 800mg tablets Renapro powder Renapro Shot 60ml bottles Renastart powder Renastep liquid Renilon 7.5 liquid Renvela 800mg tablets Renvela 2.4g oral powder sachets ReQuip 1mg tablets ReQuip 2mg tablets ReQuip 5mg tablets ReQuip XL 8mg tablets Resonium A powder Resource Energy liquid Resource Fibre 2.0 liquid Resource Junior complete sip feed Respifor milkshake style liquid Revatio 10mg/ml oral suspension Revatio 20mg tablets Revlimid 10mg capsules Revlimid 25mg capsules Revlimid 5mg capsules Revlimid 7.5mg capsules Revolade tablets (ALL) Rezolsta 800mg/150mg tablets Rifabutin 150mg capsules Rifaximin tablets (ALL) Rilutek 50mg tablets Riluzole 25mg/5ml oral suspension sugar free Rinvoq 15mg modified-release tablets Riociguat tablets (ALL) Risperidone 1mg/ml oral solution sugar free Rivastigmine 2mg/ml oral solution Rivastigmine 2mg/ml oral solution sugar free Roaccutane 20mg capsules Rocephin 2g powder for solution for injection vials Ropinirole 2mg tablets Ropiqual XL 4mg tablets Rose water liquid Rotigotine transdermal patches (ALL) Rybelsus tablets (ALL) Sabril 500mg oral powder sachets Sacubitril/Valsartan tablets (ALL) Salbutamol 2mg tablets Salbutamol 4mg tablets Salbutamol 5mg/5ml solution for infusion ampoules Salicylic acid 12% collodion Salicylic acid powder Saline 0.9% nebuliser liquid 2.5ml Steri-Neb unit dose ampoules Salofalk 1g gastro-resistant tablets Salofalk 1g/application foam enema Salvacyl 11.25mg powder and solvent for suspension for injection vials 39 Part II 04/2022 REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Samsca tablets (ALL) Sancuso 3.1mg/24hours transdermal patches Sandimmun 100mg/ml oral solution Sandimmun capsules (ALL) Saxagliptin 5mg / Dapagliflozin 10mg tablets Scandishake Mix oral powder 85g sachets Scopoderm 1.5mg patches Selenase 100micrograms/2ml oral solution 2ml unit dose ampoules Selenase 500micrograms/10ml oral solution unit dose vials Selenase 500micrograms/10ml solution for injection vials Selenium 100micrograms/2ml oral solution unit dose ampoules Seroquel 100mg tablets Seroquel 200mg tablets Seroquel 300mg tablets Seroquel XL 150mg tablets Seroquel XL 300mg tablets Seroquel XL 400mg tablets Setofilm orodispersible films (ALL) Sevelamer 2.4g oral powder sachets sugar free Sevelamer 800mg tablets Sialanar 320micrograms/ml oral solution Sildenafil 10mg/ml oral suspension sugar free Sildenafil 20mg tablets Silver nitrate powder Similac High Energy liquid Simple eye ointment Simvastatin oral suspension sugar free (ALL) Sirolimus tablets (ALL) Slenyto 5mg modified-release tablets SMA Alfamino powder SMA Althera powder SMA High Energy liquid SOD Anamix Infant powder Sodium bicarbonate 8.4% (1mmol/ml) solution for injection 10ml ampoules Sodium oxybate 500mg/ml oral solution sugar free Sodium phenylbutyrate 500mg tablets Sodium phenylbutyrate 940mg/g granules sugar free Sodium polystyrene sulfonate powder sugar free Sodium salicylate powder Sodium valproate 100mg modified-release granules sachets sugar free Sodium valproate 250mg modified-release granules sachets sugar free Sodium valproate solution for injection ampoules (ALL) Sodium valproate 50mg modified-release granules sachets sugar free Sodium zirconium cyclosilicate oral powder sachets (ALL) Solgar Chelated Magnesium 100mg tablets Solgar CoQ-10 100mg capsules Solian 100 tablets Solian 400 tablets Solian 100mg/ml oral solution Solu-Medrone 1g powder and solvent for solution for injection vials Sondate XL 200mg tablets Souvenaid liquid Spiroco XL 8mg tablets Squill liquid extract Stayveer 125mg tablets Stiripentol capsules (ALL) Stiripentol oral powder sachets (ALL) Strattera 4mg/1ml oral solution Strattera capsules (ALL) Stribild 150mg/150mg/200mg/245mg tablets Strontium ranelate 2g granules sachets sugar free 42 Part II 04/2022 REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Viread 33mg/g granules Viridal Duo Continuation Pack 20microgram powder and solvent for solution for injection cartridges Viridal Duo Continuation Pack 40microgram powder and solvent for solution for injection cartridges Vital 1.5kcal liquid Vitasavoury powder 50g sachets Voleze 4.6mg/24hours transdermal patches Volibris tablets (ALL) Voractiv tablets Voriconazole 200mg tablets Voriconazole 200mg/5ml oral suspension Wakix tablets (ALL) Warfarin 1mg/ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd) Water for injections 1litre bottles Water for injections 500ml bottles Wellvone 750mg/5ml oral suspension White liniment Wilzin 25mg capsules Wilzin 50mg capsules Xagrid 500microgram capsules Xeljanz 5mg tablets Xeomin 100unit powder for solution for injection vials Xeplion suspension for injection pre-filled syringe (ALL) Xifaxanta 200mg tablets XMET Homidon powder XMTVI Asadon powder Xonvea 10mg/10mg gastro-resistant tablets XPhe jump 10 liquid XPHEN TYR Tyrosidon Free AA Mix powder Xyrem 500mg/ml oral solution Zalasta 20mg tablets Zeffix 100mg tablets Zemplar 1microgram capsules Zemplar 2microgram capsules Zinamide 500mg tablets Zinc acetate 25mg capsules Zinc acetate 50mg capsules Zinc oxide powder Zing 220mg capsules Zofran 16mg suppositories Zofran 4mg/5ml syrup Zofran Flexi-amp solution for injection ampoules (ALL) Zofran Melt oral lyophilisates (ALL) Zofran tablets (ALL) Zoladex 3.6mg implant SafeSystem pre-filled syringes Zoladex LA 10.8mg implant SafeSystem pre-filled syringes Zolmitriptan 5mg tablets Zometa 4mg/100ml infusion bottles Zometa 4mg/5ml solution for infusion vials Zonegran 100mg capsules Zonegran 50mg capsules Zonisamide 100mg capsules Zonisamide 50mg capsules Zovirax 200mg/5ml oral suspension Zovirax Double Strength 400mg/5ml oral suspension Zyprexa 10mg tablets Zyprexa 15mg tablets Zyprexa 20mg tablets Zyprexa 5mg tablets Zyprexa 7.5mg tablets Zyprexa Velotabs (ALL) Zytiga 500mg tablets 43 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS Drugs for which discount is not deducted Zyvox 100mg/5ml granules for oral suspension Zyvox 600mg tablets 44 04/2022 Part II REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS, APPLIANCES AND CHEMICAL REAGENTS PRODUCTS INCLUDED IN CLAUSE 10B(iii) Products included in Clause 10B(iii) are listed below. Liquid preparations for external use: SubPara Name Pack(s) (c) Alphosyl Shampoo 2 in 1 (250ml) (c) Aveeno Body Wash (500ml) (c) Aveeno Lotion (500ml) (c) Aveeno Moisturising Creamy Oil (300ml) (a) Balneum Bath Oil (500ml and 1000ml) (a) Balneum Plus Bath Oil 82.95%/15% (500ml) (b) Capasal Therapeutic Shampoo (250ml) (c) Ceanel Concentrate (150ml and 500ml) (a) Cetraben Bath Oil (500ml) (c) Dentinox Cradle Cap Shampoo (125ml) (a) Dermalo Bath Emollient (500ml) (c) Dermol 200 Shower Emollient (200ml) (c) Dermol 500 Lotion (500ml pump) (c) Dermol 600 Bath Emollient (600ml) (c) Dermol Wash cutaneous emulsion (200ml) (a) Doublebase Emollient Bath Additive (500ml) (a) E45 Emollient Bath Oil (500ml) (c) E45 Lotion (200ml and 500ml pump) (c) E45 Shower Creme Emollient (200ml) (c) E45 Emollient Wash Cream (250ml) (c) Eczmol 1% Cream (250ml) (a) Emulsiderm Emollient (300ml and 1 litre) (b) Exorex Lotion (100ml and 250ml) (a) Hydromol Bath and Shower Emollient (350ml, 500ml and 1 litre) (c) Hydromol Intensive 10% Cream (30g and 100g) (b) Neutrogena T/Gel Shampoo for Dry Hair (125ml and 250ml) (b) Neutrogena T/Gel Therapeutic Shampoo (125ml and 250ml) (a) Oilatum Bath Formula (150ml and 300ml) (c) Oilatum Cream (150g, 500ml and 1050ml) (a) Oilatum Emollient (500ml) (a) Oilatum Junior Bath Additive (150ml, 300ml and 600ml) (c) Oilatum Junior Cream (150g and 350ml) (a) Oilatum Plus Bath Additive (500ml) (c) Oilatum Scalp Intensive Shampoo (100ml) (c) Oilatum Scalp Treatment Shampoo (100ml) (c) Oilatum Shower Gel Fragrance Free (150g) (b) Psoriderm Bath Emulsion (200ml) (b) Psoriderm Cream (225ml) (b) Psoriderm Scalp Lotion Shampoo (250ml) 47 Part IIIA 04/2022 PROFESSIONAL FEES (PHARMACY CONTRACTORS) See Part I, Clause 5B 1 (ii) (page 9) Fee per prescription p Endorsements required by contractors D. All prescriptions for oral liquid methadone attract a payment 250 NIL E. Where the quantity dispensed to the patient for a prescription for oral liquid methadone covers more than one dose and the contractor has packaged each dose separately 55 PD(n)* F. Where the prescription is for a Controlled Drug in Schedule 2 or 3 of the Misuse of Drugs Regulations 2001 Schedule 2 drug 128 NIL Schedule 3 drug 43 NIL G. Expensive Prescription Fee A fee equivalent to 2% of the net ingredient cost will be payable on all prescriptions over £100. Note - Expensive Prescription Fee is not included in calculation of ESPS payments *n=number of doses packaged separately minus the number of times the contractor has dispensed the medicine to the patient**. Where a numeric value is not provided, the contractor will be paid one fee. If the number of occasions when the medicine is dispensed equals the number of doses that have been packaged separately, this fee is not payable. ** an interaction with the patient where oral liquid methadone has been supplied. 48 04/2022 Part IIIB SCALE OF FEES (APPLIANCE CONTRACTORS) Part IIIB - Scale of Fees (Appliance Contractors) See Part I, Clause 5B 2(iii) (page 10) *Fee per prescription p Endorsements required by contractors * Endorsements under this heading apply only to claims for the appropriate professional fee. The endorsement codes to be used are: MF= Measured and Fitted Further endorsement may be necessary for other purposes eg Part II “CLAUSE 8 BASIC PRICE, “CLAUSE 9 ENDORSEMENT REQUIREMENTS” 1. ALL PRESCRIPTIONS attract a Professional Fee with a value of: 90 NIL 2. ADDITIONAL FEES: A. APPLIANCES (a) Elastic Hosiery (Compression Hosiery) requiring measurement and endorsed "measured and fitted" 260 MF (b) Trusses requiring measurement and endorsed "measured and fitted" 260 MF (c) Para stomal garments (belts and girdles) where size is not indicated in the Drug Tariff requiring measurement and endorsed “measured and fitted” 260 MF (d) Home delivery of Part IXA qualifying items1 (excluding catheter kits and intermittent self-catheters), Part IXB and Part IXC 340 NIL (e) Home delivery of catheter kits and intermittent self-catheters 930 NIL B. Expensive Prescription Fee A fee equivalent to 2% of the net ingredient cost will be payable on all prescriptions over £100. 1Part IXA (qualifying items) include: catheters (urinary and urethral), laryngectomy and tracheostomy, catheter accessories, catheter maintenance solutions, anal irrigation system, vacuum pumps and constrictor rings for erectile dysfunction, and wound drainage pouches. 49 04/2022 Part IV CONSUMABLES AND CONTAINERS Part IV - Consumables and Containers See Part I Clause 5B 1 (iii) 1. A Pharmacy Contractor shall supply in a suitable container any drug which he is required to supply under Part II of Schedule 2 to the Regulations. Capsules, tablets, pills, pulvules etc shall be supplied in airtight containers of glass, aluminium or rigid plastics; card containers may be used only for foil/strip packed tablets etc. For ointments, creams, pastes, card containers shall not be used Eye, ear and nasal drops shall be supplied in dropper bottles, or with a separate dropper where appropriate. 2. Payment for consumables used when dispensing is at the average rate of 1.24p per prescription for every prescription (except an oxygen prescription) supplied by contractors. This payment includes • Provision for supply of either a 5ml plastic measuring spoon (which shall comply with BS 3221:Part 6:1987), or a 1ml, 5ml or 10ml plastic oral syringe measure with every oral liquid medicine, except where the manufacturer’s pack includes one. Plastic oral syringe measures must be clearly labelled ‘oral’ and/or ‘enteral’ in a large font size, comply with appropriate British or European Standards (BS 3221:Part 7:1995 or an equivalent European Standard for the 5ml syringe) and be wrapped together with a bottle adaptor and instructions. Choice of whether a spoon or syringe (and its size) is supplied will depend on the nature of the medication regime. • In very exceptional circumstances, or where specifically requested by the prescriber, dilution may still take place. The prescription should be endorsed accordingly. • Provision for supply of a dropper bottle or separate dropper with every prescription for a medicine which is for administration to or via the ear, eye or nose, or a vaginal applicator with every prescription for contraceptive gel or cream, except where the manufacturer’s pack includes one. 3. Payment for containers will be at the rate of 10p for every prescription (except special containers) supplied where the quantity ordered is outside of the pack size (or a multiple of the pack size) for products: • Listed in Part VIIIA of the Tariff. • Not listed in Part VIIIA of the Tariff, the pack size published by the manufacturer, wholesaler or supplier is endorsed by or on behalf of the contractor. • Where the pack size is unknown by the Pricing Authority, the pack size endorsed by the contractor. For contractors who have dispensed any drug except for oral liquid methadone against an FP10MDA prescription form, as a temporary measure, for prescriptions dispensed from April 2013, this payment will be made once per instalment ie per dispensing to the patient, regardless of whether the quantity ordered per dispensing was available as a listed pack size. For oral liquid methadone, this payment will only be made where the total volume prescribed is outside a pack size listed in Part VIIIA Drug Tariff listed pack (or a multiple of). 4. Payment for consumables and containers is payable to pharmacy contractors only. 52 04/2022 Part V DEDUCTION SCALE (PHARMACY CONTRACTORS) 72001 72500 10.09 101501 102000 10.54 127001 127500 10.93 72501 73250 10.10 102001 102750 10.55 127501 128000 10.93 73251 73750 10.11 102751 103250 10.56 128001 128500 10.94 73751 74500 10.12 103251 103750 10.57 128501 129000 10.95 74501 75250 10.13 103751 104250 10.57 129001 129500 10.96 75251 75750 10.14 104251 104750 10.58 129501 130000 10.97 75751 76500 10.15 104751 105250 10.59 130001 130500 10.97 76501 77000 10.16 105251 105750 10.60 130501 131000 10.98 77001 77750 10.17 105751 106250 10.60 131001 131500 10.99 77751 78250 10.18 106251 106750 10.61 131501 132000 11.00 78251 79000 10.19 106751 107250 10.62 132001 132500 11.00 79001 79750 10.20 107251 107750 10.63 132501 133000 11.01 79751 80250 10.21 107751 108250 10.63 133001 133500 11.02 80251 81000 10.22 108251 108750 10.64 133501 134000 11.03 81001 81500 10.23 108751 109250 10.65 134001 134750 11.04 81501 82250 10.24 109251 109750 10.66 134751 135250 11.05 82251 82750 10.25 109751 110500 10.67 135251 135750 11.05 82751 83500 10.26 110501 111000 10.68 135751 136250 11.06 83501 84250 10.27 111001 111500 10.68 136251 136750 11.07 84251 84750 10.28 111501 112000 10.69 136751 137250 11.08 84751 85500 10.29 112001 112500 10.70 137251 137750 11.08 85501 86000 10.29 112501 113000 10.71 137751 138250 11.09 86001 86750 10.31 113001 113500 10.71 138251 138750 11.10 86751 87250 10.31 113501 114000 10.72 138751 139250 11.11 87251 88000 10.33 114001 114500 10.73 139251 139750 11.11 88001 88750 10.34 114501 115000 10.74 139751 140250 11.12 88751 89250 10.34 115001 115500 10.74 140251 140750 11.13 89251 90000 10.36 115501 116000 10.75 140751 141250 11.14 90001 90500 10.36 116001 116500 10.76 141251 141750 11.14 90501 91250 10.37 116501 117000 10.77 141751 142500 11.16 91251 91750 10.38 117001 117500 10.77 142501 143000 11.16 91751 92500 10.39 117501 118000 10.78 143001 143500 11.17 92501 93250 10.41 118001 118750 10.79 143501 144000 11.18 93251 93750 10.41 118751 119250 10.80 144001 144500 11.19 93751 94500 10.42 119251 119750 10.81 144501 145000 11.19 94501 95000 10.43 119751 120250 10.82 145001 145500 11.20 95001 95500 10.44 120251 120750 10.82 145501 146000 11.21 95501 96000 10.45 120751 121250 10.83 146001 146500 11.22 96001 96500 10.45 121251 121750 10.84 146501 147000 11.22 96501 97000 10.46 121751 122250 10.85 147001 147500 11.23 97001 97500 10.47 122251 122750 10.85 147501 148000 11.24 97501 98000 10.48 122751 123250 10.86 148001 149000 11.25 98001 98500 10.49 123251 123750 10.87 149001 150000 11.27 98501 99000 10.49 123751 124250 10.88 150001 160000 11.42 99001 99500 10.50 124251 124750 10.89 160001 & above 11.50 99501 100000 10.51 124751 125250 10.89 100001 100500 10.52 125251 125750 10.90 100501 101000 10.52 125751 126500 10.91 101001 101500 10.53 126501 127000 10.92 Monthly Total of Prices £ Deduction Rate % Monthly Total of Prices £ Deduction Rate % Monthly Total of Prices £ Deduction Rate % From To From To From To 53 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) Part VIA - Payment for Essential Services (Pharmacy Contractors) 1. Establishment Payments Wales only 1.1 An Establishment Payment of £12,500 is payable to pharmacy contractors. 1.2 The Establishment Payment will be paid monthly, calculated as 1/12th of the payment. 2. Practice Payments Wales only 2.1 All pharmacy contractors in Wales only will receive a Practice Payment from 1 April 2005. 2.2 Practice Payments from 1 April 2022, which includes a contribution for provision of auxiliary aids for people eligible under the Equality Act 2010 (EA) and, will be as set out in the table below: 2.3 Practice payments will be paid monthly, calculated as a proportion of the payment according to the number of months covered on the basis of the number of prescription items submitted, and reimbursed by the Pricing Authority, in the relevant month. 2.4 From 1 October 2005, in order to receive the full Practice Payment pharmacy contractors must have, and must have declared to the Pricing Authority on the appropriate claim form for the relevant month minimum dispensing staff levels as set out in the table below: * Dispensing staff include: a pharmacist; a non-practising pharmacist working as a dispenser; a pre-registration trainee (only half of the pre-registration trainees hours should be counted for this purpose) or an assistant trained to undertake the functions being performed. Where a staff member has multiple roles, only the number of hours spent supporting the dispensing process may be counted in the staffing declaration. In determining the dispensing staff level to declare on the appropriate claim form the number of hours should be rounded as follows: 0.5 or less round down to the nearest whole number of hours Above 0.5 round up to the nearest whole number of hours. Number of items per month Practice Payment from 1 April 2022 Contribution in Practice Payment to transition from 1 April 2022 Contribution in Practice Payment for EA from 1 April 2022 Up to 1,099 £600 £0 £600 1,100 - 1,499 £5,480 £0 £1,200 1,500 - 2,499 £7,656 £0 £1,500 2,500+ 32.0p per item 6.9p per item 6.6p per item Number of items per month Minimum dispensing staff level (Hours per week)* 2,000 - 3,499 40 hours 3,500 - 4,999 56 hours 5,000 - 6,499 75 hours 6,500 - 7,999 94 hours 8,000 - 9,499 112 hours 9,500 - 10,999 131 hours 11,000** 150 hours 54 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) **Pharmacy contractors will be required to employ a staff member for an extra 19 hours per week for each additional 1,500 items the pharmacy contractor dispensed per month above 11,000 items. 2.5 From 1 October 2005, where for any month a pharmacy contractor has declared to the Pricing Authority dispensing staff levels lower than those set out in the table in 2.4 above, the Practice Payment for the relevant month will be paid at the level that would be paid if the pharmacy only dispensed the number of items at the lowest level in the band that corresponds in the above table to its declared dispensing staff levels. 2.6 From 1 October 2005, where for any month a pharmacy contractor has not declared dispensing staff levels to the Pricing Authority, the Practice Payment for the relevant month will be paid at the minimum level. 2.7 Subject to 2.7.1 and 2.7.2, where total monthly payments in relation to prescriptions passed for pricing for the period April to March are less than the amount which would have been paid had the payment been calculated on the basis of the total of the relevant payments set out in the table in 2.2, pharmacy contractors may make a claim for a top up payment to the relevant LHB. They should submit, by 30 November, copies of WP34 statements for the relevant period (April to March) as evidence of the total number of prescription items passed for pricing during this period. 2.7.1 Where, in any month, Practice Payments were paid at a lower level because minimum dispensing staff levels were not met, those months shall be disregarded (in terms of both the number of items passed for pricing and the payments received) when calculating the amount of any top up payment which may be payable. 2.7.2 Where, in any month, Practice Payments were paid at a lower level because a pharmacy contractor did not declare dispensing staff levels, those months shall be disregarded (in terms of both the number of items passed for pricing and the payments received) when calculating the amount of any top up payment which may be payable, unless the pharmacy contractor can satisfy the relevant LHB that their dispensing staff levels were sufficient in respect of the table in 2.4 for the relevant month. 3. IM&T Services and Allowances (Wales) 3.1 The NHS Wales Informatics Service (NWIS) sets and delivers the strategic direction and corporate IM&T policy for Community Pharmacy in Wales. 3.2 There are parallel strategic developments within England and Wales in relation to the technical architectures that underpin the ‘NHS Care Records Service’ (England) and the ‘Welsh GP Record’ (Wales). 3.3 However, differences in direction and pace of these respective programmes have meant that Wales, via a national community pharmacy IM&T programme board of representative stakeholders, has determined appropriate and comparable solutions, deliverable through a pragmatic, phased approach. Phase 1 - IT Infrastructure and Connectivity Services 3.4 In 2005/06, two allocations of £1,300 (ie a total of £2,600) were paid to all pharmacy contractors included, at that time, in a pharmaceutical list maintained by a Local Health Board in Wales. Pharmacy contractors were directed to ensure investment in systems to support the Programme’s key objectives associated with Phase 1; specifically, that funding must be targeted to ensure any investment in IT is “fit for purpose” and capable of running the latest version of the pharmacy contractors’ PMR system. The allocations applied only to pharmacy contractors included, at that time, in a pharmaceutical list maintained by a Local Health Board. 3.5 In addition, from 2007, a recurring ‘connectivity’ payment of £200pcm is included within the Establishment Payment for all contractors capable of secure/managed access to the NHS Wales network and its connectivity services, such as web eMail and HOWIS (Health of Wales Information Services). 3.6 With effect from 30 September 2010 the recurring ‘connectivity’ payment of £200pcm, include Phase 1 and Phase 2 services. 57 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) 4.8 This provision applies to prescriptions dispensed on or after 1 December 2010. 5. Transitional Payments (England only) 5.1 From 1 January 2022, pharmacy contractors who dispense 101 prescription items or more in any month will receive a monthly Transitional Payment which consists of two separate payments - a dispensing payment and a service payment as set out in Table 1. 5.2 For the pharmacy contractors to receive the monthly service payment of the transitional payment they must have: (i) claimed for at least one New Medicine Service (NMS) in the previous month; and (ii) been registered to provide the Community Pharmacy Consultation Service (CPCS) on the Manage Your Service (MYS) platform for greater than or equal to half of the number of full days in the previous month. Example 1 For a pharmacy contractor, who dispensed 2,000 prescription items in January 2022, to receive the service payment of £60 they must have claimed for one NMS undertaken in December by the 5 January 2022 and they must have been registered on MYS to provide CPCS for at least 16 days in December 2021. Example 2 For a pharmacy contractor, who dispensed 6,000 prescription items in March 2022, to receive the service payment of £882 they must have claimed for one NMS undertaken in February by the 5 March 2022 and they must have been registered on MYS to provide CPCS for at least 14 days in February 2022. 5.3 Contractors should note that the monthly amount of Transitional Payment may change over the course of the year. Table 1 6. Essential pharmaceutical service – fee ensuring home delivery during the Covid-19 outbreak (England only) 6.1 Pharmacy contractors, who dispense the stated number of prescription items or more in any month (regardless of how many items they actually deliver to patient’s homes) and who are located in an area specified in NHS England and NHS Improvement’s announcement for the relevant time period, will receive a fee based on the number of days for which they are required to ensure prescription items can be delivered to eligible patients and also adjusted for the total number of eligible patients in the announced cohorts as outlined in NHS England and NHS Improvement’s announcement to the effect that eligible patients in the specified areas should stay away from pharmacies for reasons relating to the Covid-19 pandemic. 6.2 Pharmacy contractors, who dispense 101 prescription items or more in any month (regardless of how many items they actually deliver to patient’s homes) and who are located in an area specified in NHS England and NHS Improvement’s announcement for the relevant time period, will receive the following daily payment adjusted for the number of days for which they are required to ensure prescription items can be delivered to eligible patients for reasons relating to the Covid-19 pandemic and also adjusted for the number of eligible patients in the announced cohorts. For example, if the requirement was in place in their area for 5 days in a given month with the service eligibility for only Clinically Extremely Vulnerable patients and a Number of items per month from 1 January 2022 Monthly Dispensing Payment of the Transitional Payment from 1 January 2022 Monthly Service Payment of the Transitional Payment from 1 January 2022 0 - 100 £0 £0 101 - 2,500 £60 £60 2,501 - 5,000 £699 £699 5,001 - 12,500 £882 £882 12,501 - 19,167 £956 £956 19,168+ £993 £993 58 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) pharmacy contractor is in the 101 to 2,500 item band, they would receive a payment of £10.35. The daily payment corresponding to the six item bands are as follows: 6.3 Payments for ensuring home delivery during Covid-19 pandemic as outlined above do not apply to distance selling premises. 7. Easter 2020 opening hours (England only) 7.1 Pharmacy contractors who remained open on Good Friday 2020 and Easter Monday 2020 for 3 hours on each of these days as a direct consequence of the NHS England and NHS Improvement announcement made in accordance with paragraph 27A of Schedule 4 to the Pharmaceutical Services Regulations will be remunerated for these three hours at £250/hour. Claims for payment for this service must be made between 17 April 2020 and 5 May 2020 via the MYS platform provided by the NHSBSA 7.2 The NHSBSA will make appropriate payments claimed by the pharmacy contractor as described above on 1 June. The payment will not be separately itemised on the FP34 Schedule of Payments. However, the NHSBSA will issue letters to pharmacy contractors, who claimed as outlined above, to inform them of the payment made to them. 7.3 Pharmacy contractors who remained open on Good Friday 2020 and Easter Monday 2020 as per a local agreement with NHS England and NHS Improvement should only claim for payment as outlined above for up to 3 hours based on the number of hours they were opened. If they were opened for more than 3 hours, the balance must be claimed from the regional team as per local agreement. Pharmacy contractors must not duplicate claims for the same opening hours by claiming on MYS and through local arrangements. 8. Contribution for adjustments to support social distancing during the outbreak of Covid-19 (England only) 8.1 To allow pharmacy contractors to safely conduct essential services in pharmacy premises during the Covid-19 pandemic, a contribution of £300 will be payable to pharmacies towards the general costs of adjustments to support social distancing. 8.2 Pharmacy contractors that have temporarily closed for a period since 31 March 2020 of greater than two weeks or have applied to NHS England and NHS Improvement to be closed for a period of greater than two weeks after 31 March 2020 due to the Covid-19 pandemic will not receive the payment, unless they had installed adjustments to support social distancing prior or after the temporarily closure. 8.3 Pharmacy contractors that have remained open from 31 March 2020 and have not applied to NHS England and NHS Improvement to be closed as described in paragraph 9.2 will not need to make a claim for payment, which will be made on 1 May 2020. The payment will not be separately itemised on the FP34 Schedule of Payments. However, the NHSBSA will issue letters to pharmacy contractors to inform them of the payment made to them. 8.4 Pharmacy contractors that installed adjustments prior to or after temporarily closing and do not receive payment on 1 May 2020, can claim the payment of £300 between 5 May 2020 and 5 August 2020 using the appropriate claim form available on the NHSBSA’s website, at the following link: https://www.nhsbsa.nhs.uk/contribution-adjustments-temporarily-closed- pharmacies. The claim form must be signed by the contractor. Number of items per month Self-isolating patients only Clinically Extremely Vulnerable (CEV) patients only Self-isolating and CEV patients 0 - 100 £0 £0 £0 101 - 2,500 £0.17 £2.07 £2.24 2,501 - 5,000 £2.02 £24.24 £26.26 5,001 - 12,500 £2.55 £30.62 £33.17 12,501 - 19,167 £2.77 £33.19 £35.96 19,168+ £2.87 £34.47 £37.34 59 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) 8.5 Payments for costs of adjustments during the Covid-19 pandemic as outlined above do not apply to distance selling premises. 9. Early May Bank Holiday 2020 opening hours (England only) 9.1 Pharmacy contractors who remained open on 8 May 2020, the Early May Bank Holiday 2020 for 3 hours as a direct consequence of the NHS England and NHS Improvement announcement made in accordance with paragraph 27A of Schedule 4 to the Pharmaceutical Services Regulations will be remunerated for these three hours at £250/hour. This will also be the level of remuneration for a pharmacy open on that day as per a local agreement with the regional team, but only for up to 3 of the hours for which the pharmacy is open. Claims for payment for this service must be made between 25 May 2020 and 22 June 2020 via the MYS platform provided by the NHSBSA. 9.2 The NHSBSA will make appropriate payments claimed by the pharmacy contractor as described above on 1 July 2020. The payment will not be separately itemised on the FP34 Schedule of Payments. However, the NHSBSA will issue letters to pharmacy contractors, who claimed as outlined above, to inform them of the payment made to them. 9.3 Pharmacy contractors who remained open on 8 May 2020, the Early May Bank Holiday 2020 as per a local agreement with NHS England and NHS Improvement should only claim for payment as outlined above in 9.1 for up to 3 hours based on the number of hours they were open. If they were open for more than 3 hours, the balance must be claimed from the regional team as per local agreement. Pharmacy contractors must not duplicate claims for the same opening hours by claiming on MYS and through local arrangements. 10. Reimbursement for PPE costs incurred within community pharmacy and dispensing appliance contractors (DACs) during the Covid-19 pandemic response (England only) Background 10.1 Community pharmacies continued to operate throughout the Covid-19 pandemic. Guidance was issued on 19 March 2020 to advise on operating model changes to reduce the risk of transmission https://generalpracticebulletin.cmail19.com/t/ViewEmail/d/ 42D38571E307F65F2540EF23F30FEDED/07BD036C356575E57EEA1DAE616D4B3C 10.2 In April 2020, Public Health England (PHE) guidance on PPE for community pharmacy recommended the sessional use of Type IIR fluid-resistant surgical face masks (FRSM) where pharmacy staff are unable to maintain social distancing of 2 metres from patients (with possible or confirmed Covid-19). 10.3 Community pharmacies were invited to sign-up to the PPE portal from 3 August 2020 as an emergency supply route and then for all Covid-19 PPE requirements from 21 September 2020. Claims process 10.4 Claims must be submitted through the MYS portal (with the exception of central claims made for pharmacies with six or more branches), for PPE purchased between 27 February 2020 and 31 December 2020 for use in the delivery of NHS pharmaceutical services up to 31 March 2021, as a result of Covid-19 infection control guidance. All claims must be submitted by 12 February 2021. 10.5 Pharmacies with six or more branches may make a single central claim that must be submitted by email to nhsbsa.pharmacysupport@nhs.net. However, this must be supported by appropriate evidence, using the assigned spreadsheet to show what PPE was sent to each branch together with a cumulative total. This is being allowed on an exceptional basis because this claiming process is being implemented retrospectively. Had pharmacies known about this claims process at the time they may have established their accounting systems differently. 10.6 The items that can be claimed are aprons, gloves, Type IIR masks and hand sanitiser. Between 27 February 2020 and 30 June 2020 any protective equipment used in substitution of unavailable items can be covered under standard claims. This includes visors. Where the standard claims amount does not cover the costs for standard protection, an exceptional claim should be made. 10.7 Each pharmacy will be able to make claims under two categories: 62 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) pharmacy technician, who is responsible for maintaining the confidentiality of any personal data concerning health that is submitted as part of the claim. 11.3 On the rare occasion (see paragraph 11.4) that a pharmacy contractor might not be able to complete the NHS DMS in full, the contractor will be able to claim the following fees for the stages of the NHS DMS that have been completed (n.b. details on the action required by pharmacy contractors at each stage of the NHS DMS are provided in Chapter 8 of Guidance on the NHS (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020): • Stage 1 - £12 • Stage 2 - £11 • Stage 3 - £12 11.4 The claim for the stages of the DMS completed by the contractor must be made via the MYS portal no later than the 5th day of the month following that in which the final stage that the contractor was able to undertake was completed. Where a contractor has completed some of the stages of the NHS DMS, but not all the stages of the NHS DMS that they intend to complete, they should not yet make a claim. When a contractor does claim payment for all of the stages they provided, but not for a completed DMS referral, as part of the claim the contractor must provide one of the following reasons as to why the NHS DMS service was not provided in full to the patient. A claim for part completion of the NHS DMS may only be made where one of the reasons set out below applies: • Patient uncontactable or withdraws consent following completion of Stage 1: Where stage 1 of the service has been delivered but the patient withdraws consent to receive the service or the first prescription post-discharge is not received by the community pharmacy to complete stage 2 of the service and no contact is made by the patient, reasonable attempts must be made by the community pharmacy to contact the patient using the contact details set out in the referral. In this scenario, it is also possible that the patient has been re-admitted to hospital, has been admitted to a care home or has died. Where the community pharmacy is unable to reach the patient (or the patient has been readmitted to hospital or admitted to a care home) the community pharmacy should share any findings of concern from stage 1 of the service with the patient’s general practice before claiming payment for all of the stages they provided. • Patient moves community pharmacy after stage 1 of the service has been provided: The situation may occur where stage 1 of the service has been delivered by a community pharmacy and that community pharmacy subsequently finds out that the patient wishes to use a different community pharmacy for the provision of the service. Before claiming payment for all of the stages they provided, the first community pharmacy should contact the second community pharmacy and offer to send them via a secure electronic message (e.g. to the community pharmacy’s premises specific NHSmail account) the referral information received from the NHS trust and any relevant information and/or findings identified during stage 1 of the service. In these circumstances, the second pharmacy should also only claim payment for the stages they provided, as they will not have provided all the complete service. • Patient uncontactable or withdraws consent after completion of stage 1 and stage 2: Where stage 1 and stage 2 of the service is provided by the community pharmacy, but the patient withdraws consent to receive the service or the community pharmacy is unable to contact the patient to complete stage 3 of the service, reasonable attempts must be made by the community pharmacy to contact the patient using the contact details set out in the referral. Where the community pharmacy is unable to reach the patient, they should share any findings of concern from stage 1 and 2 of the service with the patient’s general practice before claiming payment for all of the stages they provided. • Temporary community pharmacy closures mean the complete service cannot be provided: Where a temporary community pharmacy closure of one week or more means that a community pharmacy cannot provide the service, reasonable attempts must be made by the community pharmacy to contact the patient using the contact details set out in the referral. The community pharmacy should inform the patient of the situation and identify 63 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) another pharmacy to refer the patient on to for completion of the service. In these circumstances, the community pharmacy should contact the identified community pharmacy and offer to share via secure electronic message (e.g. to the community pharmacy’s premises specific NHSmail account) the referral information received from the NHS trust and any relevant information and/or findings identified during stage 1 or stage 2 of the service if already provided. In this scenario, both community pharmacies should only claim payment for all of the stages they provided as they will not have provided the full service. 12. Reimbursement of Covid-19 costs incurred by pharmacy contractors between 1 March 2020 and 31 March 2021 and recovery of the uplift to the advance payments received between 1 April 2020 and 1 July 2020 (England only) 12.1 Pharmacy contractors can claim for specific categories of Covid-19 related costs incurred between 1 March 2020 and 31 March 2021 in delivery of NHS pharmaceutical services. 12.2 Payments will be made on 1 October providing pharmacy contractors submit their claims as per paragraphs 12.4 and 12.5, subject to the arrangements for reviews and appeals in paragraph 12.10. 12.3 The uplift to the advance payments received between 1 April 2020 and 1 July 2020 (see Part I, Clause 5C paragraph 3 for detail) will be recovered as part of the monthly reconciliation from 1 October 2021 to 1 March 2022 in six equal parts. In cases of a change of ownership, the recovered payments will reflect the advance payments received by the previous owner, where the pharmacy F-code has been retained by the current owner. 12.4 Where there has been a change of ownership of a pharmacy after 15 August 2021, and the current owner of that pharmacy has a different pharmacy F-code as a result of that change but is, for the assessment of tax purposes, an associated company of the previous owner (for example, because the company that is current owner is under the control of the same person or persons as the company that was the previous owner), the recovered payments from the current owner will also reflect the advance payments received by the previous owner. If there is no such connection but the Secretary of State is nevertheless satisfied, from the surrounding circumstances, where ownership has changed after 15 August 2021, that the current owner could have retained the pharmacy F-code of the previous owner but has changed it wholly or partly in order to avoid liability for re-payment of the advance payments that the previous owner received, the Secretary of State may determine that current owner will be liable for the recovered payments that the current owner would have been liable for, had the current owner retained the pharmacy F-code of the pharmacy. The Secretary of State will determine such cases on referral from the NHSBSA and may ask the current and/or the previous owner to supply evidence and/or make written representations before making his determination. Claims process for Covid-19 related costs of the four specified categories 12.5 All claims must be submitted to the NHSBSA between 5 July and 15 August 2021 by completing and returning the claim form. 12.6 Pharmacies with two or more branches may make a single claim and provide documentation to evidence claims at company level. 12.7 There are four categories of costs that can be claimed for. These are set out in table 1. 64 04/2022 Part VIA PAYMENT FOR ESSENTIAL SERVICES (PHARMACY CONTRACTORS) Table 1. Categories of Covid-19 costs that can be claimed for Category of costs Includes Excludes Acceptable evidence 1 Additional staff costs due to Covid-19 - Additional staff costs for backfilling staff that were ill, shielding or self-isolating due to Covid-19 - Additional staff costs to deal with the increased demand in / time needed for the provision of NHS pharmaceutical services - Additional staff costs for regular (non-Covid- 19 related) absences - Deferred annual leave - Staff costs for Bank Holiday openings (funded separately) Includes: - Invoices for locums - Overtime paid for staff - Increased overall staff bill compared to previous years 2 Costs for making premises Covid- secure - Costs for Covid-19 related cleaning/ hygiene products - Costs for messaging and barriers - Costs exceeding £300 for adjusting premises to support social distancing -PPE and hand sanitiser (provided/ funded separately) - Costs up to £300 for adjusting premises to support social distancing (funded separately) Includes: - Invoices/receipts 3 IT and communication costs to support remote working and virtual patient contact due to Covid-19 - Hardware costs (e.g. phones, laptops, webcams) - Software costs (e.g. software licences) Includes: - Invoices/receipts Additional evidence is required to demonstrate that the costs are Covid-19 related, e.g. evidence of spend in previous years, justification that these are additional costs as a result of Covid-19 4 Notified closures for infection control purposes (maximum 14 days) - Notified closures for infection control purposes where all staff had to self-isolate - Notified closures for infection control purposes of pharmacies in health centres - Closures not notified to NHSE&I - Closures not for the purpose of infections control - Closures for business reasons - Closures exceeding 14 days Contractors are asked to specify the dates and number of days the pharmacy closed following notification of NHSE&I. Following confirmation from NHSE&I that the contractor notified the closure and that the closure is in scope, contractors will be paid according to paragraph 15.8d. 67 04/2022 Part VIB PAYMENT FOR ESSENTIAL SERVICES (APPLIANCE CONTRACTORS) 2.5 The Release 2 allowance is paid only once, in relation to pharmaceutical services provided at the same premises irrespective of any subsequent merger or sale; or where there has been a relocation, there is no right to claim further Release 2 allowance for the new relocated premises. 2.6 Subject to the conditions in 2.2, an appliance contractor who operates Release 1 or Release 2 of the service if an appropriate prescription is presented or requested, shall be entitled to an ETP monthly allowance of £200 per calendar month from the NHSCB for each month that he is able to operate the service. 2.7 A contractor must submit an ETP Monthly Allowance Claim Form (previously known as form PPAETP1) to the NHSCB by the end of the first month that he is able to operate the service to receive the monthly allowance for that month and subsequent months. If at a later date the appliance contractor becomes unable to operate the Electronic Prescription Service, the contractor must inform the NHSCB in writing immediately so that the NHSCB can determine whether payment of the ETP monthly allowance should be stopped on a permanent basis or suspended for a month (or other period as specified by the NHSCB). When the EPS service is resumed, a completed ETP Monthly Allowance Claim Form will need to be resubmitted. 3. Electronic Transfer of Prescriptions (Wales) 3.1 The Electronic Transfer of Prescription (ETP) service for Wales will be deployed in phases with two separate releases (Release 1, 2D Barcoded Prescriptions and Release 2, Electronic Transmission of Claims) of ETP compliant pharmacy systems. Further details of service implementation and deployment can be found at http://howis.wales.nhs.uk/wmss. 3.2 In order to be able to use the full Electronic Transfer of Prescription service, Dispensing Appliance Contractors will need to have: • an ETP compliant dispensing system, accredited as such by the NHS Wales (firstly Release 1 and then Release 2) • appropriate NHS Wales accredited network connectivity (details of which will be made available to Dispensing Appliance Contractors by NHS Wales), to be able to operate the full Electronic Transfer of Prescription service (specifically Release 2) • designated staff to operate the service who are registered users and have been notified to NHS Wales authorities. 3.3 Any Dispensing Appliance Contractors who have dispensed more than 1200 items in the 12 months preceding 1 April 2010 will be paid an allowance of £2,600 in their June 2010 payment. Payment will automatically be triggered and no claim form needs to be submitted. If an Appliance Contractor dispenses less than 1200 items in the 12 months before 1 April 2010 or they open after 1 April 2010, if they are in a position to operate Release 1 of the Electronic Transfer of Prescription service, they may claim the allowance of £2,600 by submitting an ETP3 Claim Form to the NHS Wales Business Services Centre. Claims must be made by 31 March 2011. After this date no further payments will be made in respect of Release 1. 3.4 The Release 1 allowance is paid only once, in relation to pharmaceutical services provided at the same premises irrespective of any subsequent merger or sale; or where there has been relocation, there is no right to claim a further Release 1 allowance for the new relocated Premises. 3.5 A further allowance of £1,000 will be paid linked to the Dispensing Appliance Contractor deploying Release 2 of the Electronic Transfer of Prescription service. Payment will be automatically triggered, when a Dispensing Appliance Contractor submits a synthetic reimbursement endorsement message to NHS Wales Prescription Services Unit. This synthetic reimbursement endorsement message must be submitted to NHS Wales Prescription Services Unit by a date yet to be determined of which three months’ notice will be given, in order for the allowance to be paid. 3.6 The Release 2 allowance is paid only once, in relation to pharmaceutical services provided at the same premises irrespective of any subsequent merger or sale; or where there has been a relocation, there is no right to claim further Release 2 allowance for the new relocated premises. 68 04/2022 Part VIB PAYMENT FOR ESSENTIAL SERVICES (APPLIANCE CONTRACTORS) 3.7 Subject to the conditions in 3.2, a Dispensing Appliance Contractor who operates Release 1 or Release 2 of the service if an appropriate prescription is presented, shall be entitled to an ETP monthly allowance of £200 per calendar month from the LHB for each month that he is able to operate the service. 3.8 A Dispensing Appliance Contractor must submit an ETP1 Claim Form to the NHS Wales Business Service Centre by the end of the first month that he is able to operate the service to receive the monthly allowance for that month and subsequent months. If at a later date the Dispensing Appliance Contractor becomes unable to operate the Electronic Transfer of Prescription Service, the contractor must inform the LHB in writing immediately so that the LHB can determine whether payment of the ETP monthly allowance should be stopped on a permanent basis or suspended for a month (or other period as specified by the LHB). When the ETP service is resumed, a completed ETP1 Claim Form will need to be resubmitted. 69 04/2022 Part VIC ADVANCED SERVICES (PHARMACY AND APPLIANCE CONTRACTORS)(ENGLAND) Part VIC - Advanced Services (Pharmacy and Appliance Contractors)(England) MEDICINES USE REVIEW, PRESCRIPTION INTERVENTION SERVICE, NEW MEDICINE SERVICE, STOMA CUSTOMISATION, APPLIANCE USE REVIEW, COMMUNITY PHARMACY SEASONAL INFLUENZA VACCINATION ADVANCED SERVICE AND NHS URGENT MEDI- CINE SUPPLY ADVANCED SERVICE PILOT SCHEME Advanced Services (Pharmacy and Appliance Contractors)(England) 1. The Medicine Use Review and Prescription Intervention Service (MUR), New Medicine Service (NMS), Stoma Customisation, Appliance Use Review, the Community Pharmacy Seasonal Influenza Vaccination Advanced Service and the NHS Urgent Medicine Supply Advanced Service pilot scheme form part of the Advanced Services within the community pharmacy contractual framework. Stoma Customisation and Appliance Use Reviews are applicable to appliance contractors as well as pharmacy contractors. The relevant directions are now set out in the Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions 2013, referred to in this Part as ‘the principal Directions’. New Medicine Service Monthly Fee 2. A monthly payment will be paid for each completed full service intervention. The fee per intervention will be dependent on the number of interventions achieved for the month and whether any target has been achieved based on the monthly prescription volume of the pharmacy. The amount paid per service intervention starts at £20, but will increase with the volume of interventions subject to a target level being achieved and an overall cap of 1% of monthly prescription volume. 3. Additionally, to support patients who were prescribed a new medicine during the Covid-19 pandemic, but who did not receive the New Medicine Service (NMS) at that time, a catch-up NMS may be offered to eligible patients between 1 September 2021 and 31 March 2022 in line with the service specification. 4. Contractors can offer patients meeting the following criteria a catch-up NMS: • The patient had a medication which falls into any of the eligible therapeutic categories listed in the service specification, newly prescribed for them between 1 April 2020 and 31 August 2021; and • The patient had not previously received an NMS in respect of that prescribed medicine when it was originally prescribed. 5. The payment to be made per service intervention and the number of interventions required per month to reach a target can be found in Table 1 below. Standard and catch-up NMS will count towards the target in line with the service specification. If contractors fail to reach the first target level (10%) then all full service interventions provided will be paid at £20 each. 6. Where a target level is reached, all of the full service interventions provided up to that point are paid at the rate corresponding to the target. For example, where a pharmacy with a monthly prescription volume between 3501 to 4500 delivers 10 service interventions in the month (achieving the 20% target rate) all 10 interventions will be reimbursed at the 20% rate of £26 each. 7. The claim for activity for each month must be made by submitting the appropriate form to the Pricing Authority no later than 5th of the following month. The last claim date for activity for catch- up NMS must be made no later than 5 April 2022. 72 04/2022 Part VIC ADVANCED SERVICES (PHARMACY AND APPLIANCE CONTRACTORS)(ENGLAND) NHS Community Pharmacist Consultation Service (CPCS) 22. In England, from 29 October 2019, the following fee will be paid for the provision of the NHS Community Pharmacist Consultation Advanced Service (CPCS). Regardless of whether a medicine/appliance was supplied, a fee of £14.00 will be paid in respect of each referral received and completed by the pharmacy contractor via the NHS 111, IUC CAS or General Practice referral route into CPCS as part of the Advanced Service 23. Other referrals via NHS 111, IUC CAS or General Practice and requests by patients for emergency supplies that are not part of the Advanced Service, do not attract this fee. 24. No further fees will be paid for the CPCS where an urgent medicine is supplied, and any items dispensed will not contribute to the establishment payment and deduction scale calculations. 25. Pharmacy contractors will be reimbursed* the cost of any supplied medicine/appliance following a referral for urgent medicines/appliances supply in accordance with Part II, Clause 8 (Basic Price) of the Drug Tariff. An allowance at the applicable VAT rate will also be paid, where applicable. 26. The fee mentioned in paragraph 22 will be payable only to contractors who have registered for the CPCS scheme and who meet the requirements of the service. The registration for the CPCS scheme will be via the NHSBSA Manage Your Service (MYS) portal. 27. The service requirements are set out in directions 7BA and 7BB of the principal Directions and the NHSCB service specification. Whether or not a referral has been completed is to be understood by reference to the service specification. 28. Claims for payments for this service and for reimbursement of costs for items supplied for urgent medicines/appliances supply should be made monthly, via the Manage Your Service platform provided by the NHSBSA and/or the CPCS Pharmacy IT system (where this functionality is available). Claims will be accepted by the NHSBSA within six months of completion of a referral, in accordance with the usual Drug Tariff claims process. Later claims will not be processed. 29. The NHSBSA will make appropriate payments claimed by the pharmacy contractor as described above, in the same payment month as other payments for NHS Pharmaceutical Services and the payments will be separately itemised on the FP34 Schedule of Payments. 30. Where urgent medicines/appliances are supplied, and the patient is exempt from payment of NHS prescription charges, the pharmacy contractor must complete an FP10DT EPS dispensing token with the information required in the NHSCB service specification and ensure completion of the exemption declaration in line with paragraph 2 of Part XVI of the Drug Tariff. These completed FP10DT EPS dispensing tokens should be sent to the NHSBSA as part of the month-end submission (clearly separated within the batch and marked ‘CPCS’), which should be sent not later than the 5th day of the month following that in which the urgent supply was made*. *Subject to the contractor having submitted a claim via the Manage Your Service platform containing all of the required information, the cost of medicines or appliances supplied under this part of the service will be reimbursed using the basic price specified in Drug Tariff Part II Clause 8 (Basic Price). For clarity, no other elements of the Drug Tariff in relation to reimbursement of medicines or appliances apply to this service, including the payments for consumables and containers Claims associated with initial local engagement in preparation for delivering the GP referral pathway of the CPCS 31. From 1 November 2020, subject to the payment conditions set out in paragraph 32, pharmacy contractors will be remunerated a contribution of £300 towards the costs associated with initial engagement with local partners in preparation for delivering the GP referral pathway of the CPCS. 32. The conditions referred to above for claiming the payment for costs associated with initial local engagement, with Primary Care Networks (PCNs), GPs etc., in preparation for delivering the GP referral pathway of the CPCS Advanced Service are that contractors must: • complete the activity described at Annex F of the service specification by 30 June 2021, and • be able to produce the required documentation, if requested to do so by the NHSCB or the NHSBSA, so that it can be evidenced at a later date. Further details can be found in Annex F of the service specification. 73 04/2022 Part VIC ADVANCED SERVICES (PHARMACY AND APPLIANCE CONTRACTORS)(ENGLAND) 33. Claims for payments for this programme should be made monthly, via the webform on the Manage Your Service platform provided by the NHSBSA and available at https://services.nhsbsa.nhs.uk/ nhs-prescription-services-submissions/login. Claims will be accepted by the NHSBSA not later than the 5th day of the month following that in which the activity was completed or by 5 July 2021, whichever date is earlier. Later claims will not be processed. Each claim must include a declaration that the contractor has completed the required activity and that they can provide evidence to support the claim if requested to do so by NHSBSA. Payment will be made via the NHSBSA schedule once approved. Community Pharmacy Home Delivery Service during the Covid-19 outbreak 34. In England, a fee of £6 (this includes VAT) will be paid for each delivery to eligible patients as outlined in NHS England and NHS Improvement’s announcements. 35. The fees will be payable only to contractors meeting the requirements of the service as outlined in the updated version of the service specification available under the following link - https:// www.england.nhs.uk/coronavirus/primary-care/. Distance selling pharmacies are not eligible to provide this service. 36. Claims for payments for this service should be made monthly, via the MYS platform provided by the NHSBSA no later than the 5th of the following month. 37. The NHSBSA will make appropriate payments claimed by the pharmacy contractor as described above, in the same payment month as other payments for the related NHS Pharmaceutical Services and the payments will be separately itemised on the FP34 Schedule of Payments. 38. Local pharmaceutical services (LPS) pharmacies should note that a contract variation will apply to them to commission as appropriately a similar service from them. Community Pharmacy Hepatitis C Antibody Testing Service 39. In England, from 1 September 2020 a fee of £36 will be paid for each Hepatitis C Antibody test completed on an eligible person who injects drug (PWID) by a pharmacy contractor regardless of the result. 40. Pharmacy contractors will also be reimbursed the cost of the Hepatitis C Antibody test in accordance with the list price as published by the supplier. An allowance at the applicable VAT rate will also be paid. 41. The fees will be payable only to contractors meeting the requirements of the service including notification of the intention to provide the service to NHSCB by completing an electronic registration through the NHSBSA Manage Your Service (MYS) platform. These are set out in directions 7BC and 7BD of the principal Directions and the service specification. 42. The claim for activity for each month must be made via the MYS platform provided by the NHSBSA no later than 5th of the following month. 43. The NHSBSA will make appropriate payments claimed by the pharmacy contractor as described above, in the same payment month as other payments for NHS Pharmaceutical Services and the payments will be separately itemised on the FP34 Schedule of Payments. 44. A review of the service will be undertaken towards the end of 2021/22 to inform whether the service will be commissioned the following financial year. Community Pharmacy Covid-19 Lateral Flow Device Distribution Service 45. In England, pharmacy contractors who sign up to deliver the NHS Community Pharmacy Covid- 19 Lateral Flow Device Distribution Service as an Advanced Service will qualify for a single upfront payment of £250+VAT to support initial costs incurred in setting up the service (including the development of Standard Operating Procedures and training of all staff involved in delivery of the service). 46. From 4 October 2021 the following fees will apply: • a fee of £1.70+VAT will be paid for each completed transaction of the supply of a box or up to two boxes of Covid-19 Lateral Flow Devices from the pharmacy for self-administration at home to a person, whether for themselves and/or others, where the contractor submits a 16- digit collect code* provided by the person collecting, 74 04/2022 Part VIC ADVANCED SERVICES (PHARMACY AND APPLIANCE CONTRACTORS)(ENGLAND) • a fee of £1.20+VAT will be paid for each completed transaction of the supply of a box or up to two boxes of Covid-19 Lateral Flow Devices from the pharmacy for self-administration at home to a person, whether for themselves and/or others, where there is no 16-digit collect code*. 47. The fees will be payable only to contractors meeting the requirements of the service including notification of the intention to provide the service to NHSCB by completing an electronic registration through the NHSBSA Manage Your Service (MYS) platform. These requirements are set out in directions 7BE and 7BF of the principal Directions and the service specification. 48. Contractors do not have to claim for payments for this service. Payments will be calculated by NHSBSA from the submissions submitted by contractors via the MYS portal and outlined in the service specification from the submissions received at the end of the fifth day of the following month in line with the Drug Tariff. 49. The NHSBSA will make appropriate payments to the pharmacy contractor, on a 4 or 5 weekly cycle, corresponding to the same payment month as other payments for NHS Pharmaceutical Services and the payments will be separately itemised on the FP34 Schedule of Payments. 50. A review of the Community Pharmacy Covid-19 Lateral Flow Device Distribution Service will be undertaken towards the end of 2021. * People can access a collect code for the collection of tests via the Community Pharmacy Covid-19 Lateral Flow Device Distribution Service by registering on gov.uk or by calling 119. NHS Community Pharmacy Hypertension Case-Finding Advanced Service 51. In England, pharmacy contractors who sign up to deliver the NHS Community Pharmacy Hypertension Case-Finding Advanced Service as an Advanced Service will qualify for a single upfront payment of £440 to support initial costs incurred in setting up the service (including the development of Standard Operating Procedures and training of staff delivering the service). 52. From 1 October 2021, a fee of £15 will be paid for each patient receiving a clinic blood pressure check. A fee of £45 will be paid for each appropriate provision of ambulatory blood pressure monitoring (ABPM) to a patient in accordance with the requirements of the service. These are set out in directions 7BG and 7BH of the principal Directions and the NHSCB service specification. 53. Additionally, pharmacy contractors who deliver the following minimum number of ABPM checks each year will automatically trigger the relevant incentive payments: • 5 ABPM checks between 1 October 2021 and 31 March 2022 in accordance with the service requirements will trigger the payment of an incentive fee of £1,000, • 15 ABPM checks between 1 April 2022 and 31 March 2023 in accordance with the service requirements will trigger the payment of an incentive fee of £400, • 20 ABPM checks between 1 April 2023 and 31 March 2024 in accordance with the service requirements will trigger the payment of an incentive fee of £400. 54. Contractors who sign up after 1 April 2022 but who deliver the minimum number of ABPM activity thresholds specified for the given financial year will receive £1,000 as a first incentive payment. Furthermore, if a contractor signs up between 1 October 2021 and 31 March 2022 and fails to do 5 ABPM checks, they can earn £1000 by doing 15 ABPM checks between 1 April 2022 and 31 March 2023. No incentive fees will be available after 31 March 2024. 55. The fees will be payable only to contractors meeting the requirements of the service as set out in directions 7BG and 7BH of the principal Directions and the NHSCB service specification including notification of the intention to provide the service to NHSCB by completing an electronic registration through the NHSBSA Manage Your Service (MYS) platform. 56. The claim for activity for each month must be made via the MYS platform provided by the NHSBSA no later than the 5th of the following month. Where a clinic test leads to an ABPM which is delivered in the following month both should be claimed for together in the month following the ABPM no later than the 5th. 57. The NHSBSA will make appropriate payments claimed by the pharmacy contractor as described above, in the same payment month as other payments for NHS Pharmaceutical Services and the payments will be separately itemised on the FP34 Schedule of Payments. 77 04/2022 Part VIC ADVANCED SERVICES (PHARMACY AND APPLIANCE CONTRACTORS)(ENGLAND) D I R E C T I O N S THE NATIONAL HEALTH SERVICE ACT 2006 The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 The Secretary of State gives the following Directions in exercise of the powers conferred by sections 127, 128, 272(7) and (8) and 273(1) of the National Health Service Act 2006(a). CONTENTS PART 1 Introductory 1. Citation, commencement and application 2. Interpretation 3. Revocations PART 2 Advanced services: pharmacy contractors only 4. MUR services: general matters and pre-conditions for making arrangements 5. MUR services: ongoing conditions of arrangements 6. New Medicine Service: general matters and preconditions for making arrangements 7. New Medicine Service: ongoing conditions of arrangements 8. Duration of New Medicine Service PART 3 Advanced services: appliances 9. Establishing and maintaining stoma appliance customisation services 10. Requirements applying to stoma appliance customisation services 11. Establishing and maintaining appliance use review services for specified appliances 12. Requirements applying to appliance use review services 13. Maximum number of appliance use review services eligible for payment PART 4 Enhanced services: pharmacy contractors only (a) 2006 c. 41. Section 128 has been amended by the Health and Social Care Act 2012 (c. 7) (“the 2012 Act”), Schedule 4, paragraph 64; and section 128 has been amended by the 2012 Act, Schedule 4, paragraph 65. 78 04/2022 Part VIC ADVANCED SERVICES (PHARMACY AND APPLIANCE CONTRACTORS)(ENGLAND) 14. Enhanced services provided by pharmacy contractors SCHEDULE 1 — National Target Groups for MUR services SCHEDULE 2 — NMS medicines PART 1 Introductory Citation, commencement and application 1.—(1) These Directions may be cited as the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 and come into force on 1st April 2013. (2) These Directions apply in relation to England. Interpretation 2. In these Directions— “the 2012 Directions” means the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2012(a), as in force on 31st March 2013; “the Act” means the National Health Service Act 2006; “appliance contractor” means a person included in a list prepared under regulation 10(2)(b) of the Pharmaceutical Services Regulations (pharmaceutical lists and EPS lists); “AUR service” is to be construed in accordance with direction 11(1); “BNF” means the current edition of British National Formulary, which is published jointly by the Royal Pharmaceutical Society and the British Medical Association(b); “clinical management plan” has the same meaning as in the Human Medicines Regulations 2012(c); “Drug Tariff” has the meaning given in regulation 89(1) of the Pharmaceutical Services Regulations (the Drug Tariff and section 164: general provisions); “drugs” includes medicines; “financial year” means the period of 12 months ending on 31st March in any year; “general practitioner”, in relation to a patient, means any medical practitioner who is, or who is a member of, a provider of primary medical services that holds the registered patient list on which the patient is a registered patient; “gluten free foods” means only those gluten free foods that are listed in Part XV of the Drug Tariff (borderline substances); “high risk medicine” has the meaning given in paragraph 1 of Schedule 1; “health care professional” means a person, other than a social worker, who is a member of a profession regulated by a body mentioned in section 25(3) of the National Health Service Reform and Health Care Professions Act 2002(d) (the Council for Healthcare Regulatory Excellence); (a) Signed on 20th July 2012. (b) The Formulary is available at www.bnf.org. (c) S.I. 2012/1916. (d) 2002 c.17. Subsection (3) has been amended by the Health and Social Care Act 2008 (c. 14), section 113(2) and Schedule 10, paragraph 17, and by S.I. 2010/231. The Council’s name was changed to the Council for Healthcare Regulatory Excellence by section 113(1) of the Health and Social Care Act 2008. 79 04/2022 Part VIC ADVANCED SERVICES (PHARMACY AND APPLIANCE CONTRACTORS)(ENGLAND) “listed chemist premises” has the same meaning as in the Pharmaceutical Services Regulations; “New Medicine Service” is to be construed in accordance with direction 6(1) and (2); “MUR certificate” means a statement of satisfactory performance certificate awarded or endorsed by a higher education institute being evidence that a person has satisfactorily completed an assessment relating to the competency framework for registered pharmacists providing MUR services approved by the NHSCB (or, pending the first such approval by the NHSCB, by the Secretary of State(a)); “MUR services” is to be construed in accordance with direction 4(1); “NHS BSA” means the NHS Business Services Authority established by the NHS Business Services Authority (Awdurdod Gwasanaethau Busnes y GIG) (Establishment and Constitution) Order 2005(b); “NHSCB” means the National Health Service Commissioning Board; “NMS medicine” has the meaning given in paragraph 1 of Schedule 2; “out of hours period” means, in relation to pharmacy premises, the periods of time that are not part of the hours during which the pharmacy premises must be open by virtue of paragraph 23(1) of Schedule 4 to the Pharmaceutical Services Regulations(c) (terms of service of NHS pharmacists – pharmacy opening hours: general) (these hours are referred to in those Regulations as core opening hours); “the Pharmaceutical Services Regulations” means the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013(d); “pharmacist independent prescriber” has the same meaning as in the Pharmaceutical Services Regulations; “pharmacy contractor” means a person included in a list prepared under regulation 10(2)(a) of the Pharmaceutical Services Regulations; “pharmacy premises” has the same meaning as in the Pharmaceutical Services Regulations; “registered patient” means a patient who is included in a list that is a registered patient list for the purposes of the Primary Medical Services (Sale of Goodwill and Restrictions on Sub- contracting) Regulations 2004(e); “relevant Primary Care Trust”, in relation to a period before 1st April 2013, means the Primary Care Trust that entered into the arrangements with the contractor that are continuing, pursuant to these Directions, with the NHSCB (where such arrangements are continuing by virtue of a transfer scheme); “specialist nurse” means a person who is— (a) registered in the Nurses’ Part or Specialist Community Public Health Nurses’ Part of the register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001(f) (establishment and maintenance of register); and (b) employed or engaged by any pharmacy contractor or appliance contractor for the purposes of conducting a review of a person’s use of specified appliances; “specified appliance” means— (a) any of the following appliances listed in Part IXA of the Drug Tariff— (i) a catheter appliance (including a catheter accessory and maintenance solution), (ii) a laryngectomy or tracheostomy appliance, (a) The competency framework in place on 1st April 2013 is the one published by the Department of Health on its website, www.dh.gov.uk. (b) S.I. 2005/2414. (c) Paragraph 22 has been amended by S.I. 2006/3373 and 2009/2205. (d) S.I. 2013/349. (e) S.I. 2004/906; see regulation 2(2) of those Regulations. (f) S.I. 2002/253.